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ABSTRACT 
The human body is complemented by its microbes. Consequently, various intimate reactions between host 
and microbes have been recognized and determining the role of the microbiota in many diseases has started. 
Until the present time, most attention has been focused on the intestinal tract that contains the majority of the 
microbiota. Extensive studies on the phylogenetic composition of the microbes present in faecal material 
revealed species richness and the individuality of the intestinal microbiota, unique to each human being. 
The work described in this thesis started when the first large scale metagenome analysis of the intestinal 
microbiota for global exploitation of the potential biological functions of this ecosystem was being initiated. 
Today, approximately ten million unique genes have been identified from the human intestinal microbiota, 
but little is known about which of these genes can be expressed into proteins and the conditions under which 
the protein synthesis occurs. Therefore, metaproteomics has emerged as a discipline in order to delve into the 
biological functions of an ecosystem in a holistic manner by targeting all the proteins present. 
This thesis work describes the development of a metaproteomic approach for analysing proteins from 
the human intestinal tract. The basis of this approach is to use crude faecal material to determine bacterial 
and human proteins simultaneously. Separating the proteins by one dimensional gel-electrophoresis and 
focusing on the molecular weight region defined by the 37 and 75 kDa bands of a protein marker was found 
to be both reproducible and feasible for the comparison of several dozens of samples. In a case study on the 
metaproteome and metagenome of two individuals the benefit of utilizing matched metagenomes on the 
number of identified spectra could be demonstrated. Furthermore, a bioinformatic workflow was devised to 
increase the ratio of peptides identified per protein class. 
Applying the developed metaproteomic approach to faecal samples derived from healthy adults 
identified ecosystem specific components including surface proteins like flagellins and proteins involved in 
vitamin synthesis. The monitoring of the metaproteome over six weeks in a probiotic intervention study 
revealed time-dependent and inter-individual variations in these functions. The major finding emerging from 
this work was that the metaproteome is personalized, both over the long-term as well as in short-term. 
Therefore, the phylogenetic individuality of the intestinal microbiota was also functionally reflected. A 
different set of microbes in their specific host in combination with environmental factors will express 
specific functionalities. 
Analysing both microbial and human proteins, which represented approximately 85% and 15% of the 
total proteins respectively, allowed identifying indications of host-microbe interactions. Enzymes both for 
degrading host and microbial components were identified. Effector and response molecules of the host-
microbe dialogue were found. 
In addition, the metaproteome of a cohort of obese individuals was compared to that of non-obese 
individuals. Based on the spectral counts of the eggNOG assignments of the identified peptides the faecal 
metaproteomes of obese and non-obese subjects were significantly different from each other. In addition, 
insulin-sensitivity correlated significantly with bacterial proteins. 
In most cases, metaproteomic data was complemented by phylogenetic microarray data. This allowed 
looking at the composition and its function at the same time. Data integration revealed for example a 
correlation between Eubacterium rectale and flagellins. In the obesity study, the proportion of Bacteroidetes 
peptides in the faecal samples from the obese subjects compared to the non-obese subjects were relatively 
higher than the presence of this phylum detected by 16S rRNA analysis. This result implies biological 
activity of Bacteroidetes also in obese individuals. 
Metagenomics is still ahead of metaproteomics, both in numbers of analysed samples and available 
tools. However, a refinement of metaproteomic methodologies has started and the number of samples 
analysed is rising. Metaproteomics is one of the central disciplines to identify the key-molecules involved in 
host-microbes interactions. 
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GLOSSARY 
Activity Collection of expressed functions of a cell; in contrast to genetic material and 
potential 
Ecosystem Living environment and organisms within 
Functionality Collection of functions a cell is capable of performing 
Matched data Metaproteomic and metagenomic data originating from the same biological sample; 
matched metaproteome and matched metagenome 
Microbiota Collection of microbes living in an ecosystem 
Microbiome Collection of genes of a microbiota; also used as a synonym for microbiota 
Meta-Omics Global analysis of molecules contained in an ecosystem or microbiota with omics 
techniques that aim at the collective characterization and quantification of pools of 
biological molecules; metagenomics, metatranscriptomics, metaproteomics 
Phylogeny Evolutionary relation of organisms; nowadays mostly based on genetic comparison 
Taxonomy Hierarchical grouping of organisms according to phylogeny
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1. INTRODUCTION 
Making new biological discoveries requires two components: a special interest as well as technological 
possibilities. The discovery of microbial life by Antonie van Leeuwenhoek (1632-1723) is a good example 
from the early days of microbiology as it illustrates his keen interest in understanding a biological 
phenomenon and advancing technical developments. Van Leeuwenhoek was a careful observer and 
associated his diarrhoea to the presence of more and different little animals “animalcules”, as he called the 
microbes, in his faecal excrements. From his drawings one may conclude that he suffered from an infection 
by the protozoan Giardia. In addition, he developed lenses that later advanced into microscopes, instruments 
that are still widely used in microbiology today. Ever since, most attention for microbes living in or around 
the human body, has been focused on pathogenic microbes. However, in the late 19th century studying 
microbes being possibly beneficial to humans, such as the lactic acid bacteria, started. Microbiology has 
come a long way from these observations. Today, not only single microbial organisms are studied in 
isolation but also complete microbial communities, termed microbiota, are analysed, preferably in their 
original environment. The analysis of soil, oceans, eons-old ice, and the bodies of a variety of animals, has 
revealed huge microbial species variations and has provided indications of microbial functions. For instance, 
termites have specialized hindgut microbes helping them with degrading wood material and cows require a 
rumen microbiota to supply them with energy out of grass cellulose. By now, from all these microbial 
reservoirs, one has received most attention, as evidenced by the numbers of papers: the human being. Skin, 
the oral cavity and gut, among other body sites, are populated by microbes. In particular, the intestinal 
microbiota has become the focus of many studies that address their associations with health and disease. 
 Modern microbiology has access to a large set of sophisticated molecular tools, each of which provides 
important information on the studied ecosystem (Table 1; Figure 1). The dominant phylogenetic composition 
of a microbiota can be assessed by analysing the 16S rRNA gene; this answers the question ‘Who is there’. 
The development of a variety of high-throughput gene sequencing methods has permitted the analysis of the 
entire gene repertoire of a microbial community, also known as the microbiome. The resulting metagenomic 
information describes the functional potential of the intestinal microbes, answering the question ’What can 
they do’. At present, phylogenetic and metagenomic approaches targeting the human microbiota are 
dominating the literature. However, other meta-omic approaches that analyse microbial consortia within their 
ecosystem are required to expand our knowledge of their in vivo functions by addressing the question ‘What 
are they doing’. The metabolic net-outcome (metabolomics) has been determined in a variety of studies. To 
some extent, the transcriptional activity of the microbial ecosystems (metatranscriptomics) has been 
addressed as well. Similarly, less studied than the phylogenetic composition and metagenome is the 
metaproteome, which includes the entire collection of proteins that are present within an ecosystem. 
Studying the proteins is required to answer the question ‘What has happened’. The term metaproteome was 
first proposed in 2004 (Rodríguez-Valera, 2004). In the same year, the first metaproteomic study, which 
analysed the metaproteome of activated sludge, was published (Wilmes and Bond, 2004). It was not before 
2006, that the possibilities and challenges of metaproteomics were described in full (Wilmes and Bond, 
2006). At the start of this thesis work, only one paper had been published describing the qualitative changes 
of the intestinal metaproteome occurring during early infancy (Klaassens et al. 2007). Due to the absence of 
reference genomes that are instrumental for protein identification, less than ten proteins could be identified. 
By now, metaproteomics has found application in many different environments from contaminated soil to the 
Atlantic Ocean, from termite hind-gut to human cerumen (Benndorf et al. 2007; Warnecke et al. 2007; Feig 
et al. 2013; Georges et al. 2014). The main aims of this thesis project were to develop an approach to analyse 
the human intestinal metaproteome and then to utilize this approach to establish a baseline of a healthy 
metaproteome. 
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Table 1. Overview of state-of-the-art methods to study the human intestinal microbiota. The analytical target is named 
as well as the expected deliverables (Readout). 
Method Target Readout 
Phylogenetic analysis 16S rRNA sequences Microbiota composition and diversity  
Metagenomics All DNA present Catalogue of microbial coding capacity and 
diversity on the functional level 
Metatranscriptomics All mRNA Transcription of microbial genes as a proxy 
for their function – some host transcripts 
may be discovered as well 
Metaproteomics All proteins Expression of microbial and host genes into 
proteins as a mark for their intestinal 
function 
Metabolomics All metabolites and other small molecules Net metabolic output of the intestine derived 
from host-microbe interactions 
Culturing Single microbes Real functional analysis   
 
 
Figure 1. Tools with which to study the intestinal ecosystem. The intestinal ecosystem is directly influenced by the host 
and the environment surrounding the host. 
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2. REVIEW OF THE LITERATURE 
2.1 Human intestinal microbiota 
2.1.1 Development from birth to old age  
We are born into a world full of microorganisms, including Bacteria, Archaea and Fungi as well as their 
viruses. Consequently, these microbes also colonize us. The first cohabitants on our inner and outer surfaces 
usually derive from our mothers and there seem to be routes that expose already the foetus to microbes, 
challenging the earlier view that babies are borne completely sterile (Tissier, 1900; Jiménez et al. 2005; Jost 
et al. 2014). Recent phylogenetic analysis has revealed that a great variety of microbial communities are 
hosted by the human body, distinct to each body site and niche (Human Microbiome Project Consortium, 
2012). Each individual harbours a unique microbiota, this being influenced by both the host’s genes and 
environmental factors. However, for example the skin microbiota of two individuals is more similar than the 
skin microbiota and the intestinal microbiota within one individual, highlighting the site-specificity of the 
host-associated microbial communities.  In addition, even a single body site, such as the mouth, can contain 
many micro-environments and hence different microbial communities exist in different niches (Kort et al. 
2014). 
The intestine is not only the most complex but also the most studied of these ecosystems i.e. the 
environment and the organisms living within it (Qin et al. 2010; Karlsson et al. 2014; Li et al. 2014). The 
start-up community of the intestine may be shaped by the mode of delivery, infant nutrition – breast milk 
versus formula – and use of antibiotics, and may thereby also have an impact on health later in life (Penders 
et al. 2006; Scholtens et al. 2012; Nylund et al. 2014). Probably the most long-lasting effect of the intestinal 
community on our well-being is the stimulation of the immune-system. The intestinal microbiota plays an 
essential part in the priming of the immune system, reviewed by Weng and Walker (2013). This priming is 
needed in order to acquire the delicate balance between tolerance to antigens derived from food and 
commensals, and effective reactivity against pathogens later in life. As the human body and its physiology 
develop from infancy to adulthood, so does our intestinal microbiota. There are drastic changes taking place 
in infancy and childhood evidently affecting the microbiota. One early event is the change from nursing on 
breast milk, containing growth stimulating components for microbes (Wang et al. 2015), or formula to eating 
solid food (Bergström et al. 2014). The constant body growth and other developmental changes cause a 
constantly changing environment for the intestinal microbiota. The present studies have mostly focused on 
analysing faecal samples from infants and adults. From toddler age to adolescence less data is available and 
therefore the constant succession of the microbiota from infancy to adulthood is largely unknown. However, 
from early life until adulthood the diversity of the microbiota increases and an ecosystem rich in several 
hundreds to thousands of microbial species becomes established (Nielsen et al. 2014). At the level of 
operational taxonomic units (OTUs), unique organismal genetic units, the variation across individuals is 
tremendous, even though the main phyla in the gut are limited, including Firmicutes, Bacteroidetes, 
Actinobacteria, Proteobacteria and Verrucomicrobia. Collecting and curating 16S rRNA gene sequences at 
97% similarity derived from the human intestine as deposited in public databases resulted in the definition of 
2,473 OTUs (Ritari et al. 2015). These represent the present estimate of the number of bacterial and archaeal 
species possibly found in the human intestine, meaning that there is an almost infinite number of 
combinatorial community alternatives. In addition, more genera and species are constantly being isolated 
(Rajilić-Stojanović and de Vos, 2014). As discovered over a decade ago, each individual harbours one’s own 
personalized microbiota determined by genetic, environmental and dietary factors. As long as no drastic 
changes occur (see below), the microbiota is relatively stable and the temporal fluxes are smaller than the 
between-individual differences (Jalanka-Tuovinen et al. 2011). Therefore, the individual microbiota can be 
used for subject-identification. A challenging down-side of the large microbiota differences between 
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individuals is evident when setting up group comparisons e.g. when attempting to study the effect of a 
special dietary regime. The between-group differences are hard to detect when the within-group differences 
are already large. However, unifying patterns across a collection of individuals have been identified and a set 
of enterotypes, each dominated by a certain group of bacteria, have been proposed (Arumugam et al. 2011). 
These patterns suggest that there is a limited set of module solutions providing the integral features in the 
intestine, provided by dominating bacteria. Such patterns like the enterotypes may be useful in study design 
since stratifying for a certain enterotype may make it easier to detect group differences. Recently, also the 
microbiota diversity (Salonen et al. 2014) and the abundance of individual bacteria (Korpela et al. 2014) 
have been reported to associate with the individual heterogeneity in dietary responses. This suggests that 
different features of the microbiota can be utilized in the stratification of the study subjects and in this way 
decrease the within-group variability. 
The whole digestive tract, from the oral cavity down to the colon, provides several different niches for 
microbial colonization, with the colon exhibiting the highest microbial density (Figure 2). As nutrient 
availability and human components change along the gastro-intestinal tract (GIT), the composition of the 
microbiota changes from one end to the other. The living environment of the intestinal microbes is not static 
at all. Among other factors, the amount of oxygen, the pH that varies from acidic in the stomach to more 
neutral in the intestine, and notably bile, which is a natural detergent, affect the types and amount of 
microbes present. In addition, pH and bile can vary due to changes in the diet and these can lead to changes 
in microbial communities (Duncan et al. 2009). The microbiota is encompassed by varying human enzymes 
having their origin in the saliva, gastric and pancreatic juice, bile and, in early life, breast milk. For example, 
the human intestinal alkaline phosphatase and the salivary scavenger and agglutinin (SALSA) have been 
shown to have an effect on the growth of intestinal microbes (Lallès, 2014; Reichhardt et al. 2014). The 
microbiota is also in contact with mucus, immune components and immune cells. Inevitably, evolution has 
produced an individual host-microbiota mutualism (Quercia et al. 2014). 
The human host provides the home for the microbiota and the intestinal microbes make a recognizable 
contribution to human physiology. The most obvious factor that links men and microbes is the diet and its 
major components; carbohydrates, lipids and proteins. Out of the large variety of carbohydrates, mono- and 
disaccharides and the less complex polysaccharide starch are digested mostly by host enzymes in the upper 
GI tract and immediately taken up as they are the major energy source. However, resistant starch (RS) and 
non-starch polysaccharides (NSP), which include celluloses, pectin, and hemicellulose (xylose, mannose or 
glucose), mostly reach the colon in an undigested form. Microbes, equipped with a large variety of 
hydrolases, degrade, to different extents, these plant-derived carbohydrates, which consist of a variety of 
sugars that are linked with various glycosylic bonds (Martens et al. 2014). For example, the genome of 
Bacteroides cellulosilyticus encodes over 400 enzymes for carbohydrate degradation. In general, the 
microbial gene repertoire for hydrolysing carbohydrates is much wider than that of the host. This means that 
humans depend on microbes to degrade certain food components; this may provide flexibility to adapt to 
short or long-term changes in the diet (Sonnenburg and Sonnenburg, 2014). Certain intestinal microbes not 
only rely on carbohydrates of dietary origin, but they also have enzymatic capacity to degrade host glycans 
derived from mucus, the glycoprotein structure secreted by goblet cells that covers the epithelial cells. For 
example Akkermansia muciniphila possesses this characteristic (Derrien et al. 2004), reviewed by 
Ouwerkerk et al. (2013); in this way, they contribute to a turn-over of this complex glycoprotein structure. 
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Figure 2. Schematic representation of the human digestive tract. Left side: concentration of microbes in cfu/ml. Right 
side: human components shaping the ecosystem; body fluids are secreted to the digestive tract along the digestive 
process; the intestine is lined by epithelial cells covered with a mucus layer produced by goblet cells, in yellow; various 
immune cells are present near the epithelial cells, dendritic cell as representative (Wang et al. 2005; Lawley and 
Walker, 2013; Schuijt et al. 2013) 
While processing dietary and endogenous glycans, intestinal bacteria produce a variety of molecules that 
contain energy and/or act as bioactive molecules. The short chain fatty acids (SCFA) represent one group of 
microbial metabolites that is receiving considerable attention. Acetate, propionate, and butyrate are the major 
SCFA being formed in the intestine (Cummings and Macfarlane, 1991). In particular, butyrate is of special 
interest as it is both energy source and a signalling molecule for the epithelial cells. Several metabolic 
pathways for forming butyrate have been described (Louis et al. 2010). Similarly, propionate can be 
produced by different enzymatic routes (Reichardt et al. 2014). The main butyrate producers are members of 
Ruminococcacea and Lachnospiraceae, the key species being Faecalibacterium prausnitzii and Roseburia 
intestinalis, Anaerostipes caccae and Eubacterium hallii. Microbial networks exist for cross-feeding as 
certain species depend on the presence of other microbes and their contribution of certain substrates (Scott et 
al. 2013). For example Bifidobacterium ssp. produce lactate and acetate during growth on the polysaccharide 
inulin. These metabolites are further utilized by other bacteria, e.g. E. hallii, to produce butyrate. 
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Similarly to the hydrolases for degrading glycans, intestinal microbes possess genes with coding 
capacity to transform bile salts to a diverse range of metabolites. These metabolites have been shown to play 
a role in modulating the host’s energy metabolism, reviewed by Li and Chiang (2015). 
In addition, the GIT microbiota produces a set of proteinases. Microbial proteinases derived from 
pathogens have been shown not only to digest proteins but also to have non-proteolytic properties such as 
signalling to the host (Jarocki et al. 2014). However, as proteinases have been proposed to play a role in 
inflammatory bowel disease (IBD), it is likely that also commensal proteinases can have other properties 
than proteolytic ones (Steck et al. 2012). 
Intestinal microbes also contribute to the micronutrient supply and synthesize vitamins, for example B 
vitamins (LeBlanc et al. 2013). However, absorption by the host is not always proven. Thiamine has been 
shown to be synthesized by the intestinal microbiota and also human transporters exist implying the 
absorption by the host (Nabokina et al. 2014). Bacterial vitamin synthesis capacity seems to vary according 
to geographic region and depend on food supply and age (Yatsunenko et al. 2012). This indicates that 
vitamins of microbial origin contribute to the host’s vitamin supply. In contrast to vitamins, our GIT 
microbiota for example depends on the trace element iron from the host’s diet, as reviewed by Kortman et al. 
(2014).   
Changes in the metabolic activities of the intestinal microbiota possibly occur with old age. When the 
hormone set-up, the levels of physical activity, and nutrition habits are changing, the microbiota changes as 
well. In centenarians, it has been found that an increase in the levels of inflammation, so called 
inflammaging, was associated with a reduction in the numbers of butyrate-producing F. prausnitzii and an 
increase in the levels of potential pathogens (Biagi et al. 2010; Rampelli et al. 2013). 
2.1.2 Variation and modulation in adulthood  
The first component in a human’s life affecting the composition of an individual’s intestinal microbiota is the 
personal gene make-up. Twin studies have revealed that host genetics to some extent explain the 
composition of the intestinal microbiota (Zoetendal et al. 2001; Turnbaugh et al. 2009; Tims et al. 2012). In 
addition, single nucleotide polymorphisms have been shown to affect the intestinal community structure; this 
has been documented for the gene encoding fucosyl transferase (fut2) that determines the secretor-status of 
the host (Wacklin et al. 2014). The secretor-status profoundly affects the intestinal ecosystem as only in 
secretors the intestinal mucosa is decorated with fucose, a carbohydrate abundantly utilized by intestinal 
bacteria. Secretors and non-secretors have been shown to exhibit compositional differences in their 
microbiota. This provides one of the first examples with a known mechanism to explain how the host 
genotype shapes the intestinal microbiota (Wacklin et al. 2014). However, these are still early days of 
integrating the two extremely complex systems and trying to link variations in the gut microbiome to those in 
the human genome. 
Second, diet, as introduced above, is inevitably influencing the intestinal community. However, only a 
few human studies have been conducted that describe the daily differences in diet and the different macro- 
and micro-nutrient content. For example, in a cross-over study in which study participants consumed either a 
control diet, a diet high in RS or high in NSPs, or a weight loss-inducing diet, it was found that changes had 
occurred in microbial composition upon diet-switching (Walker et al. 2011). The effect of diet, attributable 
to food components, on the human intestinal microbiota has been reviewed recently (Salonen and de Vos, 
2014; Graf et al. 2015). The microbial metabolomics profiles in vegans and omnivores have been compared, 
the effect of energy-content of diet on microbial composition has been studied, and metagenomic, 
metatranscriptomic and phylogenetic composition changes in response to a meat-fat based diet analysed 
(Jumpertz et al. 2011; Wu et al. 2014; David et al. 2014). In addition, differences in microbial composition 
and metagenomes in different ethnic groups have been detected (Yatsunenko et al. 2012; Tyakht et al. 2013; 
Schnorr et al. 2014; O’Keefe et al. 2015). These studies possibly reflect the different diets of the ethnic 
groups but it should be noted that these studies also compare populations with profound differences in 
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hygiene level, general lifestyle, and host genetics. Flexibility in metabolic activities similar to that of the host 
is to be expected, reviewed by van Ommen et al. (2014). Therefore, setting aside extreme diets, most dietary 
interventions in healthy adults only lead to subtle changes in the microbiota (Salonen and de Vos, 2014). A 
recent meta-analysis including three different intervention studies on obese patients on different dietary 
interventions showed that some individuals’ microbiota may be responsive and others not upon dietary 
changes (Korpela et al. 2014). In a study, where healthy individuals consumed a mixture of seven milk-
fermenting bacterial strains only subtle changes were found, as observed at the transcriptional level. The 
microbial composition remained unchanged (Mahowald et al. 2009). According to the definition provided by 
the World Health Organization (WHO), probiotics are "live micro-organisms which, when administered in 
adequate amounts, confer a health beneﬁt on the host". They encompass a wide range of different species and 
have been widely used for example to modulate gut transit time (Dimidi et al. 2014). On microbial 
composition in healthy individuals, only subtle effects, if any at all, have been observed in response to the 
consumption of probiotics (Gerritsen et al. 2011). 
Third, the health status of a person can impact on the intestinal microbiota. Many associations between 
microbiota and disease have been reported. Moreover, indirect effects are well studied, such as by the usage 
of antibiotics. Also direct impact is likely but often it is not known whether the changes in the microbiota are 
causal or a consequence of the disease. Dramatic changes in an individual’s microbiota can occur upon 
antibiotic treatment as reviewed recently (Panda et al. 2014). It has been proposed that if no resilience is 
achieved, i.e. the changes to the intestinal microbial composition upon antibiotic usage are not balanced, 
infections by Clostridium difficile can occur (Song et al. 2013). These infections can become life-threatening 
in the case when C. difficile produces toxins in the intestine.  Infections by C. difficile have been efficiently 
treated by introducing the microbiota from a healthy donor (Bookstaver et al. 2013; van Nood et al. 2013). 
This is evidence that the microbiota is causal both for the reoccurrence of the disease and its cure, one rare 
example of causality in a highly complex system. 
There is a large number of diseases that may involve the intestinal microbiota (de Vos and de Vos, 
2012) ranging from intestinal diseases, such as IBD (Cantarel et al. 2011; Machiels et al. 2014) and irritable 
bowel syndrome (IBS) (Kassinen et al. 2007), to systemic conditions or diseases like obesity (Everard and 
Cani, 2013), non-alcoholic fatty liver disease, and diabetes type II (Vrieze et al. 2012), and even neuronal 
disorders such as Parkinson’s disease (Scheperjans et al. 2014). In most cases, differences in composition 
have been detected but mechanistic explanations are missing.  In addition, it needs to be demonstrated 
whether these associations are a consequence or cause of the disease. Obesity and related metabolic 
aberrations represent one of the most actively studied diseases in relation to the intestinal microbiota. Studies 
addressing obesity-related phylogenetic profiles have yielded controversy results (Finucane et al. 2014). 
Those might be due to the applied methodology but also to the study cohort as the severity of obesity 
differed in the compared studies (Walters et al. 2014). On the other hand, several mechanisms that link gut 
microbiota to obesity and metabolic diseases have been proposed. These include increased energy harvest 
from the diet via SCFA production, enhanced fat storage as well as promotion of low-grade inflammation 
that contributes to development of insulin resistance (Moreno-Indias et al. 2014).  This clearly shows that the 
functionality of the microbiota has to be studied in addition to the composition in order to understand the 
host-microbe cross-talk in obesity. 
2.2 Methods to study the human intestinal microbiota 
2.2.1 Faecal material as the study object 
The easiest access to the human intestinal microbiota is faeces, which contains microbes and molecules that 
reflect as closely as possible the activities in the colon (Cummings, 1975). Since faeces can be obtained in a 
non-invasive manner, human studies targeting the intestinal microbiota have been mostly based on the 
analysis of faeces. In contrast, very few studies have involved samples taken from the ileum, intestinal 
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mucosa (biopsies) or were conducted from other types of specimens such as luminal washes or biopsies 
(Booijink et al. 2010; Li et al. 2011). These studies clearly show that each compartment has its distinct 
microbiota with its own distinct functions. 
The components of faeces, which originate from host, food and microbes, reflect the whole digestive 
process. Faeces has been used as a cure for over thousand years and its composition has interested scientists 
for more than 100 years (Joslin, 1901). The bacterial mass represents more than half of the faecal wet weight, 
half of which were found to be intact microbial cells although many of these cells were not alive (Stephen 
and Cummings, 1980; Ben-Amor et al. 2005). Research has moved from describing the composition of 
faeces to using it for discriminating between different body conditions. Individual human proteins have been 
studied in faeces and used as disease markers e.g. calprotectin, a calcium binding protein derived from 
human neutrophils, is utilized as an inflammatory marker in  inflammatory bowel disease (Foell et al. 2009). 
Elevated levels of calprotectin were also measured in a cohort of obese individuals indicating an inflamed 
state of the intestinal ecosystem in individuals with a high BMI (Verdam et al. 2013). 
The liquid phase of faeces, termed faecal water, has been widely used to test for toxic compounds, as 
reviewed by Pearson et al. (2009). Recently, faecal water has also been used to study the net outcome of host 
and microbiota metabolism and turn-over by metabolomics, both by nuclear magnetic resonance (NMR) and 
mass spectrometry (MS) techniques (Gao et al. 2009; Wu et al. 2010; O’Keefe et al. 2015). Since the 
metabolites present in faeces do not reflect the proportion of absorbed molecules and metabolites, it may be 
complemented with blood analysis to measure systemic metabolites. For example, the levels of plasma lipids 
have been determined and correlated to the intestinal microbial composition (Lahti et al. 2013a). Recently, 
several studies assessing the metabolites in faeces appeared. For example differences in microbial 
metabolites between chocolate-eaters and non-chocolate eaters were detected; another study described the 
effect of moderate wine consumption (Rezzi et al. 2007; Dewulf et al. 2013; Jiménez-Girón et al. 2014). 
2.2.2 Phylogenetic analysis  
The intestinal microbiota is phylogenetically rich, spreading over the three domains of life Bacteria, Archaea 
and Eukaryotes. There is a constant up-dating of phylogenetic grouping and classification (Rajilić-Stojanović 
and de Vos, 2014). Fungi and Archaea are more genetically deeply branched but also less researched than 
Bacteria, which represent the majority of intestinal microbes. However, Archaea, like Methanobrevibacter 
smithii and Methanosphaera stadtmanae, are of special interest due to their role in hydrogen disposal and in 
the production of methane that regulates the fermentation rate of some species (Gaci et al. 2014). Viruses add 
an additional “phylogenetic” complexity to the intestinal ecosystem. Similarly to the mycome, the virome 
has just started to be studied, but it should not be neglected when aiming to understand the entire intestinal 
ecosystem (Norman et al. 2014). 
The traditional way of identifying the phylogeny of a microorganism has been its isolation by culturing 
and studying its structural, physiological and biochemical characteristics such as cell-wall structure with 
Gram-staining and substrate preferences via feeding tests.  There is the assumption that the majority of the 
world’s microbial biodiversity has not been cultured yet (Rappé and Giovannoni, 2003). At present, 1,057 
intestinal microbial species have been cultured; 957 Bacteria, 92 Fungi, and 8 Archaea (Rajilić-Stojanović 
and de Vos, 2014). These represent less than half of the almost 2,500 known OTUs. Many of the intestinal 
microbes are strict anaerobes or are otherwise very demanding regarding their preferred culture and growth 
conditions. Moreover, some microbes may be obligate syntrophs and cannot be grown as pure cultures, or 
may grow very slowly demanding a patient researcher and long term funding. 
Molecular tools have been instrumental in exploring the microbial species variety. One specific gene has 
been established to categorize the phylogeny of an organism i.e. the gene encoding the 16S rRNA, an 
essential part of the prokaryotic ribosome. The 16S rRNA is an approximately 1,500 nt molecule, consisting 
of conserved gene regions and nine hypervariable parts. These characteristics make it an ideal phylogenetic 
marker and its sequence reflects evolutionary distance. The conserved regions are used to design nucleic acid 
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primers for amplification of a broad range of species whereas the hypervariable part can be used for species 
identification or at least clustering it to its nearest neighbour. 
Quantitative polymerase chain reaction (qPCR) assays have been used to quantify certain microbial 
genera or species (Rinttilä et al. 2004). For community-wide microbiota studies 16S rRNA gene-based 
microarrays have been developed, such as the human intestinal tract chip HITChip (Rajilić-Stojanović et al. 
2009). Microbial fingerprints have been used to compare the stability of the microbiota over time and 
relative differences of individual taxa between individuals and study groups. For example, phylogenetic 
fingerprints have shown clustering according to an individual’s health status such as the presence of IBD and 
obesity (Erickson et al. 2012; Verdam et al. 2013) and also served as predictors of the effect of diet (Korpela 
et al. 2014). 
As sequencing technologies have advanced and costs are sinking, phylogenetic analysis has reached a 
next level of sophistication. Instead of analysing a predefined set of phylotypes, the full diversity of specific 
microbiota can be explored. Next generation sequencing (NGS) techniques, sequencing techniques that 
followed the Sanger sequencing protocol and outperform it in terms of throughput and costs, made the global 
analysis of 16S rRNA possible. Sequencing platforms and strategies for gene assembly are reviewed in 
(Nagarajan and Pop, 2013).  Accumulation of 16S rRNA sequences from various environments necessitate 
selection of publically available 16S rRNA for an annotation of the sequence reads as specific as possible. 
This will ease to find differences between individuals as those are more likely to occur at the species or even 
strain level rather than at the genus or higher levels. Such a database has been created recently for the 
intestine containing 2,473 OTUs, as indicated above, compared to over 100,000 contained in the 16S rRNA 
sequence repositories SILVA and Greengenes (Ritari et al. 2015). Accumulation of genomic and 
metagenomic data has supported the development of a software tool called Picrust that infers functions from 
the phylogenetic composition based on 16S rRNA gene information (Segata et al. 2012). 
Although technical developments have greatly facilitated phylogenetic analysis, one main factor still 
remains to complicate between-study comparisons i.e. DNA extraction. Large differences in the abundance 
of the major phyla have been found across studies that cannot be explained only by the sample origin 
(Lozupone et al. 2013). For simultaneous lysis of a diverse mixture of cells ranging from Gram-positive 
Firmicutes to Gram-negative Bacteroidetes, mechanical lysis by bead beating has been shown to be the less 
biased method (Salonen et al. 2010).  In addition to DNA-extraction, sequencing specific biases such as the 
choice of primers, especially which variable region they are targeting, and the analytical platform used, 
affect the result of phylogenetic composition analyses (Lozupone et al. 2013). 
2.2.3 Metagenomics  
A number of technological developments including advanced PCR (Williams et al. 2006), next generation 
sequencing technologies, and new gene assembly strategies (see above) have made it possible to target the 
complete genetic content of microbial communities. Several studies have taken advantage of metagenomics 
to examine the genetic variety of the intestinal microbiota (Table 2). Sophisticated data processing strategies 
are required if one wishes to efficiently analyse the complex data generated. Hence, the recent years have 
seen the construction of several pipelines for processing raw sequence reads up to gene annotation, such as 
Medusa (Karlsson et al. 2014), Metaphlan (Segata et al. 2012), MEGAN (Huson and Weber, 2013), as well 
as metaProx that has been designed for faster annotation (Vey and Charles, 2014). 
In the late 2000s, two large projects focusing on the human microbiota were launched: the European 
MetaHIT with about 20 million Euro funding from the European Union focusing on the intestinal microbiota 
and the U.S. Human Microbiome Project HMP funded with over 100 million US $ from the National 
Institutes of Health, targeting microbiota at various body sites. Following the initial discovery of a baseline 
of 3 M genes, at the end of the MetaHit project, a total of 511 Europeans and 368 Chinese individuals had 
had their intestinal microbiota sequenced (Qin et al. 2010; Li et al. 2014). The HMP has sequenced over 500 
human intestinal genomes as a reference data set to facilitate the assignment of metagenomic reads (Human 
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Microbiome Jumpstart Reference Strains Consortium et al. 2010). In addition, the microbiota from all body 
cavities of more than 100 subjects has been determined (Morgan et al. 2012). In both projects also data 
analysis tools were developed and the data has been made available to the scientific community (MetaHIT: 
http://meta.genomics.cn; HMP: hmpccad.com). The HMP has continued as integrated HMP (iHMP) which 
will focus more on the functionalities of the microbiota (Integrative HMP (iHMP) Research Network 
Consortium, 2014). 
Having started from sequencing clone libraries based on Sanger technology (Gill et al. 2006), the 
technological advances have been  reflected in the rapid increase of the number of samples analysed in a 
single study, constantly increasing the number of sequenced nucleotides and the lengths of the reads while 
reducing the amount of time and money needed. Therefore, the number of analysed human metagenomes 
went up from two in 2006 to over 1,000 in 2014. Most studies have focused on identifying the genetic 
richness and coding capacity of the human microbiome with the focus on adults and European and U.S. 
inhabitants (Table 2). Mostly, the sequencing platforms HiSeq (Illumina) and 454 (Roche) have been used in 
the various projects. The fact that the next generation sequencing technologies is developing very rapidly is 
illustrated by the fact that less than ten years after its launch, the 454 sequencing platform is no longer 
supported by its manufacturer. 
The intestinal metagenomic sequencing efforts were recently combined into two separate gene atlases 
containing close to and over 10 Million microbial genes (Li et al. 2014; Karlsson et al. 2014; Table 2). Based 
on the data of both atlases, it was found that a core microbiome of close to 300,000 genes was shared by 50% 
of the study population. In the dataset collected by Karlsson and co-authors (2014), 1.3 million genes were 
reportedly shared by at least 20% of the population. The functional richness was assessed in the dataset 
collected by Li and co-authors (2014) and a total of 6,980 KEGG orthologous groups (KOs) (42.1% of 
genes) and 36,489 eggNOG orthologous groups (60.4% of genes) were identified (gene orthology databases 
like KEGG and eggNOG are detailed in 2.2.5). In the atlas reported by Karlsson and co-authors (2014) it was 
found that the  core genes, i.e. genes found in at least 50% of the subjects, derived mainly from Bacteroides 
and Clostridium spp., which was to be expected as the majority of the intestinal microbiota belongs to the 
phyla Bacteroidetes and Firmicutes. More than 67% of the genes were without KO or known function but 
when looking at core genes,  this number was reduced to 55% - this could indicate a bias in the annotation 
level of the shared house-keeping functions or just reflect the fact that more attention has been given to 
annotate the genomes of core bacteria. The fact that only half of the genes have been annotated indicates 
that, to a large extent, the functional individuality still has to be discovered. The explanation why individuals 
are either more or less prone to develop a certain disease or react in a specific way to a food component may 
lie in these unknown functionalities. 
In addition to metagenomes, sequencing of single microbial genomes is relevant for genome annotation 
and protein identification (see below). During recent years, there has also been a tremendous effort expended 
in these analyses. In 2007, there were only 306 bacterial genomes with 28 originating from the digestive 
system from Homo sapiens at the IMG/JGI system. The most recent release (04.02.2015) contained 23,908 
bacterial genomes, out of which 1,847 had Homo sapiens as the host and in these, 398 digestive system as 
origin (1,034 genomes unclassified). The enormous increase of the number of sequenced bacterial genomes 
during the last years has been reviewed recently (Land et al. 2015). 
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2.2.4 Metatranscriptomics 
One step down the cellular machinery to gene expression is the transcription into mRNA. However, since 
transcripts of bacteria and archaea have a short half-life, the design of the experimental approach and the 
preparation of the samples should be appropriate. In babies, where the metabolic turn-over is high and the 
intestinal transit usually very fast, transcripts may provide crucial information about intestinal activity. In 
adults mucosal or ileal samples are very appropriate for mRNA analysis and have provided essential insight 
into the metabolic conversions occurring in the upper intestinal tract where the microbes compete with the 
hosts for carbohydrates and form various trophic chains (Zoetendal et al. 2012; Zoetendal and de Vos, 2014). 
Moreover, this approach has revealed the functional activity of ingested Lactobacillus strains (Marco et al. 
2010). In contrast, faecal samples from adults have been studied but the functional information which can be 
obtained from these specimens may be limited to the stable messengers (Booijink et al. 2010). It has been 
described that the digestive process in the human intestinal tract can last for up to six days (Cummings et al. 
1978). 
Since the mRNA should be processed immediately, transcriptional analysis of faecal samples may be 
not become routine practice. Similar to 16S rRNA analysis, transcriptome analysis has moved from mere 
profiling and analysing a set of pre-defined mRNAs on a microarray to targeting each microbiota 
individually by sequencing mRNAs in an approach called RNAseq (Hampton-Marcell et al. 2013). Although 
faecal metatranscriptome data has to be interpreted with caution due to the above mentioned technical 
challenges, the present studies have provided evidence of the differences between potential function and 
regulated functions in vivo. In a recent study conducted in healthy men, the metatranscriptomes differed 
more than the metagenomes, reflecting the importance of functional studies as gene expression depends on 
many different factors (Franzosa et al. 2014). When individuals were challenged with a meat-fat based diet, 
samples clustered with KEGG assigned RNAseq data according to the diet but the taxonomic clustering 
remained subject-specific implying a strong effect of diet on microbial transcriptional activity (David et al. 
2014). 
2.2.5 Metaproteomics 
Proteins are the real key-players of any physiological process. Among others, they can process substrates 
providing metabolic energy, have signalling and control functions within and outside the cells, have 
structural functions, and make a cell mobile. It is important to address the actual function out of the many 
possible ones encoded by the microbiome in order to obtain a more profound understanding of the activities 
of the intestinal ecosystem and the host-microbe interactions. Proteins are the ultimate targets for this as they 
determine the function of a cell. Moreover, protein synthesis is an energy-demanding process. For example 
in E. coli it was found that two thirds of the total energy used for growth was spent on protein biosynthesis 
(Neijssel and Mattos, 1994; Jewett et al. 2009). Hence, proteins are proxies of activity and since they are 
rather stable (Taverna and Goldstein, 2002) their analyses both represent information of on-going activities 
and those having taken place in the recent past. The term proteome describes the unity of proteins expressed 
at a certain time under a certain condition in an organelle or organism. This has to be expanded in the context 
of faecal metaproteomics as first reported by Klaassens and co-authors (2007) when they conducted a study 
in human babies. As detailed above, faecal material may contain proteins, or their fragments, derived from 
all steps of digestion. Therefore, faecal metaproteomics aims at analysing proteins expressed over a period of 
time. The proteins present in saliva (Harden et al. 2012), gastric fluid (Kam et al. 2011), bile acid (Barbhuiya 
et al. 2011), pancreas (Schrimpe-Rutledge et al. 2012; Paulo et al. 2013), and amniotic fluid (Michaels et al. 
2007) have been characterized. 
Large-scale analysis of proteins, i.e. measuring hundreds to thousands of different proteins in one run 
has become possible due to the progress in two techniques i.e. liquid chromatography (LC), enabling the 
separation of several thousands of peptides based on their differences in hydrophobicity within a few hours, 
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and mass spectrometry, making accurate mass measurement possible. Metaproteomics has advanced from 
the two dimension gel-electrophoresis (2-DE) approach followed by matrix assisted laser 
desorption/ionization time-of flight (MALDI-ToF) MS analysis to exploit mainly the 1-DE approach 
followed by LC tandem mass spectrometry (MS/MS), called GeLC-MS/MS. Instead of separating proteins 
according to their isoelectric point and molecular weight followed by the analysis of a limited set of proteins 
(2-DE), complex protein mixtures are fractionated by their molecular weight only (1-DE). The GeLC-
MS/MS approach allows the analysis of a large mixture of peptides which are analysed in a single step by 
nano-high-performance LC-MS/MS. Reverse phase (RP) columns consisting of C18 molecules are used and 
a gradient increasing in hydrophobicity is applied to supply the mass spectrometer for peptide measurements. 
The various aspects of faecal metaproteomics have been reviewed recently (Study V of this thesis); the 
salient features of this discipline are summarized below (Figure 3). 
Figure 3. Overview of a metaproteomics workflow with proposed specifications based on this thesis work. 
Sample preparation 
Prior to LC-MS/MS analysis, the proteins need to be liberated from the sample matrix. As in all meta-omics 
techniques, a large collection of organisms can be the molecule-source for these proteins. Similarly, the 
proteins may be extracellular or intracellular.  The available options for metaproteomics include the analysis 
of faecal water, chemical or mechanical lysis of either microbial cells, or all of the cells present in faeces. All 
of these options have found application in faecal metaproteomics but a systematic comparison such as for 
other metaproteomic samples like soil and activated sludge has yet to come (Keiblinger et al. 2012; Hansen 
et al. 2014). Due to limitations of the nano-HPLC and the mass spectrometers, complex protein mixtures 
need to be fractionated. This can be achieved by fractionation with 1-DE, followed by dividing the gel into 
several fractions that are then separately analysed by LC-MS/MS. Peptide mixtures can also be separated by 
strong cation exchange (SCX) chromatography and the resulting fractions analysed by reverse phase LC-MS. 
Another possibility is to inject the complex mixture into the LC and run a shallow gradient for a long period 
of time (see below). 
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LC-MS/MS 
Proteins are relatively stable molecules (see above) and this eases their analysis. To increase throughput, the 
proteins are digested into peptides prior to being subjected to MS. In order to reach the mass spectrometer 
after elution from the chromatographic columns, the peptides need to be charged by ionization. The mass 
analyser sorts the peptide ions according to their mass to charge (m/z) ratio and a detector measures their 
intensities. Modern mass spectrometers are usually hybrids containing two mass analysers; one high accurate 
mass analyser measuring the mass of intact peptide ions i.e. parent ions and, for easing down-stream peptide 
identification, one less accurate but fast mass analyser for fragmenting peptide ions and analysing the masses 
of the fragment ions. Several solutions are available for each component of a mass spectrometer, i.e. 
ionization source, mass analyser, and detector. These are compatible with each other and many different set-
ups exist (Schneider and Riedel, 2010; Graham et al. 2011). There are also different methods available for 
fragmenting peptide ions (Guthals and Bandeira, 2012) resulting into different ion types. Typically, in 
metaproteomics studies, the peptides are ionized after nano-LC by electro-spray ionization and their m/z 
value analysed by hybrid mass spectrometers. The fragmentation is carried out by collision-induced 
dissociation leading to the production of mostly b- and y-ions, a fragmentation pattern which is appropriate 
for peptide-identification. Since its invention in the late 1980s, mass spectrometers have undergone rapid 
developments, both in terms of accuracy of the m/z determination and of speed of molecules analysed within 
a certain time window. In this thesis, this is illustrated by the fact that with the mass spectrometer used in 
Study IV five times more fragments were measured in the same time window (duty cycle) compared to 
Study I. These developments allow the analysis of complex protein mixtures, such as those derived from 
environmental systems, including the human intestinal tract. The invention of nano-HPLC allows the 
injection of few l and therefore sample availability is mostly not the bottle neck. This is a clear advantage to 
2-DE. 
Despite the fact that only a limited number of human intestinal metaproteomic studies have been 
reported, various options for sample preparation and data analysis have been described, reflecting the 
multitude of options the proteomics tool box is offering. Least variation is seen in the LC-MS/MS setup 
reflecting the 1D gel/gel-free approaches and nano-LC plus Orbitrap as state of the art. In the faecal 
metaproteomics approaches, three major pipeline solutions have been applied: 2-DE followed by LC-
MS/MS, 1-DE followed by LC/MSMS, and SCX chromatography coupled to LC-MS/MS (SCX RP LC-
MS/MS) (Table 3). The sample complexity of environmental samples is generally higher than in classic 
proteomics studies where the proteins originate from one organism and are usually present in a homogenous 
sample matrix. In addition, one dogma for proteomics i.e. that all (or at least the majority) of expected 
proteins is contained in the sequence database (Nesvizhskii, 2014), is hardly fulfilled in metaproteomics. The 
discrepancy between the large interest in metaproteomics and its analytical challenge is expressed by the fact 
that the number of review articles exceeds the number of experimental articles. An overview of the human 
intestinal metaproteomic studies highlighting the differences in analytical approaches, used databases and 
outcome in protein numbers and identified functionalities has been recently published (Study V of this 
thesis). Since its publication, three additional studies have been reported which are focusing on method 
development and those are detailed in the Results and Discussion section of this thesis (Lichtman et al. 2013; 
Xiong et al. 2014; Tanca et al. 2015). One additional study described proteomic differences between healthy 
controls and patients with Crohn’s Disease (CD) based on 2-DE profiles of faecal proteins (Juste et al. 2014). 
Of note, the 16S rRNA analysis did not reveal any grouping according to the health status among the studied 
samples, highlighting the added value of proteome compared to conventional microbiota analysis based on 
phylogeny. 
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Table 3. Features of pre-fractionation techniques applied in human intestinal metaproteomics. 
Feature 2-DE 1-DE  SCX 
Required protein amount > 10  µg 1-10 µg 0.01 -0.001 µg 
Throughput sample 
preparation  
Low  
 
Medium  
 
High  
Throughput LC-MS/MS Low  Medium  Low  
Identification efficiency  10 – 100 proteins from one 
sample 
>500 proteins from one 
sample 
>500 proteins from one 
sample 
2-DE: two dimensional gel electrophoresis; 1-DE one dimension gel electrophoresis; SCX: strong cation exchange 
Peptide identification 
There are three main routes for inferring a peptide sequence to an m/z value. Those are peptide spectral 
matching (PSM), “de novo” sequencing, and the use of spectral libraries (Lam et al. 2008; Allmer, 2011; 
Vaudel et al. 2012). Most frequently applied is PSM which relies on matching parent and fragment ions 
against an in-silico digest of a protein sequence database. Many different algorithms have been developed for 
performing this task; these are available via open source tools or commercial software (Shteynberg et al. 
2013). The choice of the protein sequence database is a very crucial one due to the complexity of the 
analysed samples in faecal metaproteomics. Hence, this is an essential step in the whole metaproteomic 
pipeline which is elaborated in the Results and Discussion part of this thesis. De novo sequencing i.e. direct 
inference of a peptide sequence from the m/z value is not yet routinely used in metaproteomics (Cantarel et 
al. 2011; Muth et al. 2015) as statistical methods to control for false positive identifications need to be 
developed. Spectral libraries, i.e. high quality reference m/z repositories, do not yet exist for metaproteomics. 
Since PSM is a probability-based approach, the number of false positive identifications has to be 
controlled and kept on a low level (Jeong et al. 2012). One common method is to use the results from PSM 
against a decoy database, which for example can be the sequences from the target database in reverse or a 
shuffling of the amino acids (Yadav et al. 2012). This approach has been introduced for classical proteomics 
and it has been shown that there is still improvement regarding sensitivity and accuracy of PSM in 
metaproteomics (Muth et al. 2015). False discovery rate estimations at the protein level are impaired by the 
problem of assigning peptides to proteins in metaproteomics. As the same peptide can be part of proteins 
originating from various species, phyla or even domains of life, protein inference is put to its extreme in 
metaproteomics. Therefore, analytical strategies are required to increase the statistical validity of PSM in 
metaproteomics. 
Specific post-translational modifications (PTMs) have not been considered in any human intestinal 
metaproteome study, as the complexity is already extremely high. A large variety of bacterial PTMs is 
known and includes phosphorylation, methylation and glycosylation, reviewed by Cain et al. (2014). In 
general, targeted proteomics approaches are required to identify for example phosphopeptides, reviewed by 
Huang et al. (2014). A proteomics approach has shown that some of their very abundant glycolytic enzymes 
of Lactobacillus rhamnosus GG are phosphorylated (Koponen et al. 2012). A large variety of PTMs are to be 
expected to be identified from intestinal metaproteomes. 
Quantification 
In addition to identify the different proteins in the metaproteome, quantifying their amounts is required for 
sample comparison. Absolute quantification cannot be achieved in high-throughput proteomics but basic 
approximations for assessing protein quantity exist and are very useful. Two major approaches can be taken: 
labels can be introduced to compare between different samples based on the ratio of the differently labelled 
peptides, but also label-free quantification has been made possible during the last decade due to technical and 
software improvements (Seifert et al. 2012; Otto et al. 2014; Arsène-Ploetze et al. 2014). The latter approach 
has been mostly applied in faecal metaproteomics. Label-free analysis is either based on the chromatographic 
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peaks of MS1 data, i.e. is the unity of all measured peptide ions, to compare peak intensities across 
experiments. This requires sophisticated software to adjust for differences in chromatography and peak 
intensities (aligning and normalization). Another, more simplistic but effective approach is counting the 
spectral hits for a certain unit (that may be proteins, peptides, taxonomic or functional unit). Various 
normalization methods have been described, reviewed by Neilson et al. (2011). 
During the last decade, selected reaction monitoring (SRM) methods, also called multiple reaction 
monitoring (MRM) methods, have been developed to quantify targeted proteins, reviewed by Liebler and 
Zimmerman (2013). Proof-of-principle studies identify proteins of interest and then a method is established 
to quantify these proteins. In a study on the metaproteome of the mucosal samples of CD patients a subset of 
proteins that were found to be significantly differently expressed in the 2-DE experiments, were targeted and 
verified with SRM/MRM (Juste et al. 2014). All of the SRM/MRM experiments of the thirteen proteins 
verified the earlier 2-DE results. Recently, SRM methods for 10,000 human proteins have been published 
(Rosenberger et al. 2014). In future, such methods may also be developed in large scale to target specific 
microbial proteins derived from the human intestine. 
In general, the evaluation of an approach is crucial for developing a method for multi-sample 
comparisons, especially when a multitude of options is available for each single analytical step. Already for 
the 1D separation and consequential protein in-gel digestion, a variety of choices have to be made and these 
will influence the subsequent results (Speicher et al. 2000; Glatter et al. 2012). Hence, the evaluation of a 
metaproteomic pipeline needs to be carefully planned and executed. 
The technical development in MS-based proteomics poses a challenge for data analysis and data storage 
(data repositories) as well as handling the constantly increasing size of raw files. A file containing the 
MS/MS spectra of a single sample or gel slice can be as large as 0.5 GB. Improvements have been achieved 
by standardisation of files for across-pipeline usage and public data repositories to enable reanalysis with 
constantly improving data analysis tools. For example, analysis solutions have been developed, with cloud 
computing to maximize compute resources (Muth et al. 2013). To handle these big data, software packages 
for data visualization are required; these have been reviewed recently (Oveland et al. 2015).  
Proteomics applied in microbiology 
Proteomics has been widely used to study microbial activity but there are only very few studies on 
commensal intestinal microbes, in-vitro as well as in animal model (Schneider and Riedel, 2010; Otto et al. 
2014). Performing a literature search on PubMed on 15/02/23 with the term “proteomics”  in combination 
with either “pathogen”, “probiotic”, or “commensal” resulted in 1657, 81 and 55 hits, respectively. For 
example, the pathogen Staphylococcus aureus has been studied for its response to glucose-starvation using a 
proteome approach (Michalik et al. 2012). A reference proteome was reported for L. rhamnosus GG which is 
widely marketed as a probiotic and consumed world-wide, and this paradigm probiotic strain was analysed 
by proteomics in several culture conditions also resembling the intestinal environment (Koskenniemi et al. 
2009; Koskenniemi et al. 2011; Koponen et al. 2012). Recently, the same group of researchers analysed the 
surface proteome of L. rhamnosus GG as this possibly contains the interacting molecules in the host upon 
consumption and identified expected secreted proteins as well as a set of moonlighting proteins (Espino et al 
2015). Other probiotic or model strains that have been studied by proteomics are L. plantarum WCFS1 
(Cohen et al. 2006), Bifidobacterium longum subsp. infantis (Kim et al. 2013), Propionibacterium 
freudenreichii (Le Maréchal 2015), and Weissella confusa (Lee et al. 2008). One example of a commensal of 
which its proteins were studied is Enterococcus faecalis (Lindenstrauß et al. 2013). In addition to measuring 
activity, proteomics has recently been used to identify microbial strains by MALDI in the case of 
Bifidobacterium animalis (Ruiz-Moyano et al. 2012). 
Similarly, the proteome of several human body compartments have been determined as detailed above, 
but only rarely the data is also searched against bacterial sequence entries. 
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Inferring functions to proteins  
Once a new genome is sequenced, the function of its genes or proteins is inferred from homology analysis 
with previously annotated genes or proteins; in the best case scenario the functions of selected genes are 
discovered by knock out, overproduction and phenotypic analysis. Due to the exponential growth of 
sequenced genes and therefore hypothetical proteins, experimental proof of the functions of these genes is 
lagging far behind. In the most recent release of the Universal Protein Resource Knowledgebase 
(UniProtKB) (2015_02 of 04-Feb-2015), the curated part Swissprot database contained 547,599 entries 
(http://web.expasy.org/docs/relnotes/relstat.html), whereas the non-curated part Trembl contained more than 
100-fold more sequences, with 90,860,905 sequences (http://www.ebi.ac.uk/uniprot/TrEMBLstats/). It 
appears that the Swissprot database has reached a plateau whereas in Trembl the number of sequences is 
doubling approximately every year. Evidently, this generates the problem that annotation of new genes 
mostly relies on non-curated sequences and therefore introduces biases. 
There are several approaches linked to extensive databases that can be used to assign proteins to 
functional groups (Table 4). They differ in terms of the number and type of genomes on which the 
classification has been based on. In addition, the amount of levels for functional grouping varies and can be 
shallow like for the Cluster of Orthologous Genes (COG) (Tatusov et al. 1997) or more branched like the 
Kyoto Encyclopedia of Genes and Genomes orthology (KO) (Kanehisa et al. 2004). The Cluster of 
Orthologous Genes was originally built for bacterial proteins but extended for human functions as well 
(Koonin et al. 2004). However, there has been a break of more than ten years in updating this classifier as a 
result of funding issues. Considering the tremendous increase in sequenced genomes, this clearly created 
insufficient coverage but the recent 2014 update provides a reasonable starting position (Galperin et al. 
2015). The database eggNOG built on the COG database but has a higher sequence coverage and therefore 
provides a good candidate for the functional annotation of especially bacterial genomes (Jensen et al. 2008). 
Recently, the Metaproteome Analyser (MPA), a pipeline which ranges from PSM to functional 
annotation, was released (Muth et al. 2015). One sample can be analysed with a collection of up to four non-
commercial search algorithms within one analysis process. The interface allows representing the taxonomic 
and functional results in overview graphs. However, for this feature uniprot identifiers are required to infer 
taxonomy and function and cannot be used in all metaproteomic approaches yet, as many protein candidates 
for metagenomic protein sequence databases do not contain uniprot identifiers. 
Table 4. Overview of gene orthology databases. 
Database Description Source 
COG Cluster of orthologous 
genes 
(Galperin et al. 2015) 
25 functional families 
4,631 different COGs  
711 full length eukaryotic, archaeal and 
bacterial genomes 
http://www.ncbi.nlm.nih.gov/COG/ 
eggNOG non-supervised 
orthologous groups (Powell et 
al. 2014) 
25 functional families 
1,700,000 orthologous groups 
Full length genomes 
3,686 organisms (eukaryotic, archaeal and 
bacterial) 
http://eggnog.embl.de 
KEGG  
(Kanehisa et al. 2012) 
18,449 KEGG orthologies (KO) 
(2015/2/18; inferred from KEGG GENES 
16,055,760), 469 pathway maps as one 
part of the KEGG database 
one KO may belong to a variety of higher 
levels 
last free version 2011 
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2.2.6 Data integration 
Studying the genes, transcripts, proteins or metabolites of the human intestinal microbiota all have their 
individual challenges. However, for a systemic understanding, different perspectives have to be taken at the 
same time and different data sets need to be integrated. Recent integrated approaches of the intestinal 
metaproteome followed a simple path and mainly described the study cohort (with only a limited set of 
subjects) from different angles and reported the similarities or differences with different data sets, like 
metagenomics and metatranscriptomics (Erickson et al. 2012; Ferrer et al. 2013; Daniel et al. 2014). Real 
integration still needs to be further enforced, as it is exemplified in this thesis, by using different types of 
data, like correlating the abundance of present community members with proteins to explain certain health 
conditions. Models of metabolic fluxes and network-modelling can be integrated as well (Faust et al. 2012). 
The term systems biology has been largely used for single organism studies but as analytical methods as well 
as bioinformatics are advancing, it is now possible to examine the human intestinal microbiota in a systems 
biological approach (Dos Santos et al. 2010; Siggins et al. 2012; dos Santos et al. 2013). Especially for 
generating hypotheses, intestinal models, as reviewed in (Venema and Van den Abbeele, 2013), as well as 
animal models help in reducing the complexity of the intestinal ecosystem. These hypotheses can then be 
tested in human trials. The differences between mice and humans have been reviewed recently (Nguyen et al. 
2015). When testing the effect of diet on a consortium of 12 human bacterial strains in a mouse model, 
transcriptomics, composition analysis and proteomics revealed different changes at each analytical level 
(McNulty et al. 2013). The share of unique peptides per strains in the in vivo community was different to the 
predicted contribution based on genome comparison. These findings evidence the need for studying the 
intestinal community with complementary omics methodologies, not only to increase the insight, but also to 
reduce biases of each of the approaches. A new methodology is the use of stable isotope probing (SIP) that 
has been used to identify the bacteria with active metabolic conversions in an intestinal model and could also 
be used in humans to study protein fluxes (Kovatcheva‐Datchary et al. 2009). Recently, SIP has been used to 
study the active community found in mouse intestinal biopsies (Berry et al. 2013). 
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3. AIMS OF THE STUDY 
The main aim of the thesis work was to characterize the intestinal ecosystem based on the proteins identified 
from faecal material. In detail, there were four main aims of this study: 
 
I) To develop methods for assessing the metaproteome from the human intestinal tract and implement these 
in a proof-of-principle study; 
 
II) To determine the intestinal functionalities and their short-term variance in healthy adults in the context of 
a probiotic intervention; 
 
III) To conduct a comparison of the intestinal functionality of non-obese and obese individuals based on 
microbial and host proteins; 
 
IV) To evaluate the methodologies which can be used to study the metaproteome of the human intestinal 
microbiota. 
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4. MATERIALS & METHODS 
4.1 Study cohorts and samples  
During the course of this work faecal samples from four different study cohorts were analysed (Table 5). 
The individuals in Study I took part in the Micro-Obese cohort recruited from the large SU.VI.MAX2 
cohort, in which individuals had been followed for eight years for their healthy nutritional and lifestyle habits 
(Hercberg et al. 2004). 
For Study II, which was a proof-of-principle study to assess the reproducibility of the developed 
approach and to determine the variation over time, samples were collected in-house from adults who 
provided informed consent. 
The study participants in Study III were a sub-set of a larger cohort of initially 68 individuals taking part 
in a probiotic trial testing three different probiotic strains in a double-blind setting (Lactobacillus rhamnosus 
GG, 1010 cfu per day; Bifidobacterium animalis ssp. lactis Bb12, 108 cfu per day; and Propionibacterium 
freudenreichii ssp. shermanii JS, 1010 cfu per day). The study product, to be consumed daily for three weeks, 
was a 250 ml fruit-based milk-drink without or with the probiotic strains. The set-up of this trial, the 
determined immune-markers and lipids, and the correlation between levels of lipids and the microbiota had 
been reported previously (Kekkonen et al. 2008a; Kekkonen et al. 2008b; Lahti et al. 2013a) (Figure 4). 
Metaproteomic analyses were carried out on samples from eight individuals from the placebo group and 
from eight individuals from the L. rhamnosus GG group. 
In Study IV, the intestinal metaproteomes were analysed in faecal samples from nine lean (BMI > 18.5 < 
25 kg/m2), four overweight (BMI > 25 < 30 kg/m2), and 16 obese subjects (BMI > 30 kg/m2; N=4); of these 
seven were morbidly obese (BMI > 45 kg/m2). The microbial composition and clinical host variables had 
been determined previously (Verdam et al. 2013). 
Table 5. Overview of study cohorts analysed in this thesis 
 Study Type Country of 
sample 
collection 
Subjects No. 
(Female:Male) 
Timepoints 
(intervals) 
Sample 
storage 
Age 
range 
BMI 
Study I Observational 
study 
France 2 (0:2) 1 Fresh 61-63   < 30 
Study II Proof of 
principle study 
Finland 3 (3:0) 2 (1y/  
1/2 y) 
-70° C 23-35 < 30 
Study III Placebo 
controlled 
probiotic 
intervention 
Finland 16 (11:5) 3 (3 weeks) -20° C o/n  
 -70° C 
27-54 18.4– 
30.4 
Study IV Comparative 
study 
The Netherlands 29 (20:9) 1 +4° C  
 -20° C 
within one 
day 
18-54 18.6– 
60.3 
 
 
Figure 4. Study design of Study III with respect to the analyses described in this thesis. 
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4.2 Methods 
4.2.1 Metaproteomics 
Study I was conducted within a collaboration in which the proteins had already been extracted from faecal 
samples by first isolating microbial cells by Nycodenz gradient centrifugation (Murayama et al. 2001), 
followed by disruption of the cells by chemical lysis, as described in Study I in this thesis. In all other studies 
an in-house developed sample preparation approach was applied that included the following key features: i) 
no fractionation of faecal material, ii) extraction of proteins via mechanical lysis with bead beating (0.1 mm 
zirconium silicate beads) under anaerobic condition (gaseous nitrogen), and iii) protein fractionation into 
three parts according to molecular weight by one dimensional gel-electrophoresis with focusing on the 
approximately 40-80 kDa fraction. The proteins contained therein were termed the Abundant MetaProteome 
AMP (see Results and Discussion). 
The details of the applied metaproteomic methods have been described in the original articles (Studies I-
IV). Table 6 presents an overview of the applied metaproteomic techniques from sample preparation to data 
analysis as applied in the four sub-studies. 
Table 6. Overview of proteomics methods applied in this thesis  
   Study 
   I II III IV 
Sample 
Preparation 
Protein Extraction From microbes isolated from faecal material 
(=bacterial pellet) 
X    
  From unfractionated faecal material  X X X 
  Detergent buffer (urea, thiourea, CHAPS) X    
  Phosphate buffered saline (PBS)  X X X 
  FastPrep FP120 (Savant) @ 0.1 mm zirconium 
silicate beads 
 X   
  FastPrep 24 (MP Biomedicals) @ 0.1 mm 
zirconium silicate beads 
  X X 
 1D PAGE NUPAGE 4-12% Bis-tris (Invitrogen); reducing 
agent, sample buffer, and MES running buffer 
(Biorad) 
X X X X 
 Fractionation 20 gel pieces per gel lane X    
  3 gel pieces per gel lane, analysis focus on AMP  X X X 
 In-gel digestion (Shevchenko et al. 2006) X X X X 
 Peptide clean-up GF/C filtration and OMIX tips   X  
  C18 microspin columns    X 
HPLC-ESI-
MS/MS 
Nano-HPLC Gradient run length (min): 50, 85, 100, and 120, 
respectively 
X X X X 
 Mass spectrometers  LTQ-Orbitrap X    
  LTQ-Orbitrap XL  X   
  Orbitrap Velos   X  
  Velos Pro-Orbitrap Elite    X 
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Table 6 continued 
Data-analysis Peptide spectral 
matching – search 
algorithm 
OMSSA (Geer et al. 2004) X X X X 
  X!Tandem (Craig and Beavis, 2004)    X 
  q-value correction (Käll et al. 2008); filtering of 
ambiguous hits 
   X 
 Peptide spectral 
matching – database 
Matched metagenomes, collection of bacterial 
genomes (=synthetic metagenome) + unmatched 
metagenome 
X    
  Gut dedicated database (db)  X   
  Extension of db in Study II   X X 
  Separate search against subsets of db   X   
  Search against complete set of sequences in db   X X 
 Peptide grouping   X   
 False discovery 
rate(FDR) estimation  
Concatenated target and decoy db 
 
X X X  
  Separate target and decoy db    X 
 FDR stringency 1 % X    
  5 %  X X X 
 Functional 
assignment 
COG BLAST (Tatusov et al. 1997; Altschul et 
al. 1997) 
X X X  
  KEGG assignments through NCBInr BLAST 
and subsequent MEGAN 5 analysis (Huson and 
Weber, 2013) 
  X  
  EggNOG (Powell et al. 2014); Ublast (Edgar, 
2010) 
   X 
 Functional grouping  iPath (Letunic et al. 2008)  X   
  microbial gastro-intestinal metabolic modules 
GMM (Le Chatelier et al. 2013) 
  X  
 Taxonomic 
assignment - Lowest 
common ancestora 
(LCA) 
In-house python scripts – UniprotKB  X   
  Unipept (Mesuere et al. 2012)   X X 
 Quantification Progenesis LCMS (MS1 based)  X   
  Spectral counting (MS/MS based)b X  X X 
 a Peptide matching against UniprotKB entries with 100% identity; assignment of lowest taxonomic unit to which the 
peptide was uniquely mapped; in each case all the hierarchical levels were reported allowing the sub-setting of the 
data e.g. for bacterial peptides  
b Counting of the number of spectra identified per comparative unit e.g. KO or phylum; relative percentages in 
Studies I - III; absolute numbers in Study IV   
4.2.2 Phylogenetic microarray analysis 
In addition to the metaproteomic data, phylogenetic data was available. The experiments for nucleic acid 
based analysis were carried out by our research team (Study II and III) and collaborators (Study III, Study 
IV). In Study II and IV, faecal DNA was extracted by mechanical lysis as described in (Salonen et al. 2010) 
and in Study III with a modified Promega method as described in (Ahlroos and Tynkkynen, 2009). 
Of all samples in Studies II-IV, with the exception of four samples in Study III, the Human Intestinal 
Tract Chip (HITChip), a phylogenetic microarray described previously (Rajilić-Stojanović et al. 2009), was 
used to identify the bacterial composition of the faecal samples. The results of the microbiota composition in 
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studies III and IV had been reported previously (Verdam et al. 2013; Lahti et al. 2013a). The HITChip 
targets the V1 and V6 hypervariable regions of the 16S rRNA gene of over 1000 bacterial phylotypes. 
Phylogenetic organization of the microarray probes and data pre-processing have been explained in detail 
elsewhere (Rajilić-Stojanović et al. 2009; Salonen et al. 2010; Jalanka-Tuovinen et al. 2011). In Studies III 
and IV, the probe signals were summarized with Robust Probabilistic Averaging algorithm (fRPA) (Lahti et 
al. 2013b) per phylotype and further to 131 genus-like levels, which are groups of bacteria sharing ≥90% 
sequence identity, and referred to with species name and relatives. 
4.2.3 Statistical analysis 
In studies II-IV, the statistical programming language R was used for statistical data analysis (R-core team). 
Unsupervised methods  
For the correlation of various data-sets either Pearson (Studies II and III) or Spearman correlation was used 
(Study IV). The Jaccard Index (Levandowsky and Winter, 1971), in this case “number of shared 
peptide/peptide union”, was used to compare the metaproteomes at the level of identified peptide sequences 
(Study III). Complete linkage hierarchical clustering was applied to visualize sample relationships (Studies 
II-IV). Principal component analysis (PCA) (Venables and Ripley, 2002) was used as the ordination method 
to identify feature based clusters (Study II). In addition, principle coordinate analysis PCoA was used to 
identify sample clusters based on distances (Paradis et al. 2004). Jackknife iteration was used to test the 
statistical significance of the separation. Random forest analysis of ANOVA results was applied in Study II 
(Breiman, 2011; Faraway. 2002). Q-value corrections were applied. Wilcoxon test was used to test for group 
differences (Study IV). 
Supervised method  
Boots-trap aggregated redundancy analysis (bagged RDA), applied and described in (Jalanka-Tuovinen et al. 
2014), was used to identify the NOGs explaining most of the clustering of the study groups in Study IV. 
4.2.4 Additional data-sets used in this thesis 
Study I Study II Study III Study IV 
Metagenomic reads, 
NCBI BioProject 33303, 
samples NO1 and NO3 
Phylogenetic microarray 
data 
Phylogenetic microarray 
data; 
Symptom diary 
Phylogenetic microarray 
data; 
Clinical host variables 
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5. RESULTS AND DISCUSSION 
The general objective of the work described in this thesis was to gain a functional insight into the intestinal 
microbiota based on a metaproteomic analysis of human faecal material. For this purpose, appropriate 
sample preparation methodologies and a data analysis pipeline had first to be developed. These analytical 
strategies were applied to faecal samples collected from a total of 50 adults across four different studies. The 
functional individuality of the microbiome and changes in it occurring over time were addressed. In addition, 
possible modulations of these functions due to both a probiotic intervention and to obesity were followed. 
While the emphasis was placed on addressing the microbial functionalities, the developed approach also 
enabled the simultaneous analysis of the host functions. 
5.1 Method development to study the human intestinal metaproteome (I, II and V) 
At the start of this project only one faecal metaproteomic study had been published, describing the 
metaproteome of baby faeces in the first 100 days of life (Klaassens et al. 2007). However, this first study 
was based on the classical 2-DE approach, before the appearance of the high throughput LC-MS/MS 
analytical technologies, and furthermore, it targeted baby microbiota which has a low complexity as 
compared to the adult microbiome. Moreover, no reference databases were available for the intestinal 
proteins. Hence, here a novel methodological pipeline had to be developed for analysing faeces obtained 
from adults; i.e. starting from refining the methodologies for preparing faecal samples for LC-MS/MS 
analysis and through different stages to finally devising a strategy for complex data-analysis. First, protein 
extraction and fractionation methods needed to be developed, applicable for the analysis of several dozens to 
hundreds of samples (Study II). Second, in the peptide spectral matching, as large a collection as possible of 
target sequences was needed with which to construct an intestine-specific database. As the sequence analysis 
of the intestinal metagenome has made very rapid progress, this database had to be updated (Studies I-IV). 
Third, a set of different gene orthology systems were applied to functionally annotate peptides and proteins, 
as no established system for the human intestinal proteins existed (Studies I-IV). Fourth, since previously the 
phylogenetic origin of a peptide had not been inferred from intestinal proteins, this was undertaken for the 
first time (Studies II-IV). Moreover, statistical approaches, like the Jaccard index and the integration of 
metaproteomic and phylogenetic data, originating from different disciplines were adopted for 
metaproteomics (Studies II-IV). Finally, a critical assessment of the methodologies used in human 
metaproteomics studies was performed and future needs and directions of human metaproteomics were 
proposed (Study V). 
5.1.1 Analysis of the abundant metaproteome (II) 
Mechanical lysis of microbial cells from adult faecal samples using a bead beating procedure had been 
shown to generate high yields of DNA that were suitable for determining the phylogenetic composition of a 
microbial ecosystem (Yu and Morrison, 2004). Hence, this method was applied to extract proteins from adult 
faecal samples. Similarly to the amount used for DNA extraction applied in Studies II-IV, a total of 125 mg 
faecal material was used as starting material (Salonen et al. 2010). Bead beating of the sample after three 
fold dilution in PBS with 500 mg zirconium silicate beads, for cell disruption, and three glass beads, for 
homogenization during the lysis process, under a gaseous nitrogen atmosphere resulted in protein 
concentrations high enough to produce highly visible Coomassie stained protein bands appropriate for 
consecutive nano-LC-MS/MS analysis. 
Proteins were fractionated according to their molecular weight by 1-DE. In addition to the size 
separation, this also provided a significant purification of the protein extracts and no further cleaning of the 
sample was needed anymore as these often results in dilution and the subsequent necessity to concentrate the 
samples. The 37 and 75 kDa bands of a pre-stained marker were used as molecular weight controls in the 
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production of three gel fractions: one containing proteins larger than 80 kDa, one with a molecular weight 
range of approximately 40-80 kDa and one with proteins smaller than 40 kDa. The proteins contained in 
these fractions were called High molecular weight MetaProteome HMP, Abundant MetaProteome (AMP), 
and Low molecular weight MetaProteome (LMP), respectively. The proteins contained in the ~40-80 kDa 
region were termed AMP as the majority of proteins were covered in this region. By comparing the three 
molecular weight fractions, it was observed that 81.4% of the different proteins across all fractions were also 
identified in the AMP (Study II, 6 biological samples). A further motivation to focus on this area was that it 
may be difficult to identify high molecular weight proteins and the lower molecular weight fraction is likely 
to contain ribosomal proteins and partially digested proteins. In Study II, where the approach was published 
for the first time, AMP was referred to proteins present in the 35-80 kDa region. This terming was based on 
few individuals’ samples. Later, when analysing dozens of different samples, it was noticed that cutting the 
gels below the 35 kDa marker band may not always be convenient and a cutting above is required in order to 
have sample intrinsic marker bands for cutting which might be slightly above the 37 kDa band of the pre-
stained marker. On average, in the AMP, almost 5500 unique peptides and 460 NOGs, as indicator for 
functional depth, were identified in one LC-MS/MS experiment with the experimental specifications as 
provided for Study IV (Table 6). 
Due to the complexity of the sample matrix and the proteins present in faecal material one sample 
preparation approach will always allow identification of only a subset of proteins present in the sample. 
Therefore, recently, various methods have been described that could increase the number of proteins 
identified in a metaproteomic experiment. Two main approaches are available for the identification of low-
abundance proteins in the intestinal metaproteomes, i) separating the faecal fractions and ii) fractionation of 
proteins. Two recent studies described approaches to separately analyse bacterial and human proteins 
(Lichtman et al. 2013; Xiong et al. 2014). Analysing the proteins present in faecal water identified 53 human 
core proteins in a sample size of three individuals (Lichtman et al. 2013). This number corresponds to the 23 
human KOs - which are a higher abstraction level than proteins - found to be the human functional core in 
Study III (data analysis this thesis; core defined as number of KOs identified in at least one sample of each 
individual). Therefore, the approach described here that is based on taking crude faecal material covers the 
same range of human proteins as assessed in the so-called targeted approach. The tedious separation 
described by (Xiong et al. 2014), which included several sample-preparation steps to separate human and 
microbial cells from each other, appeared to double the number of identified microbial proteins by two-fold 
compared to an approach analysing both fractions at once. Therefore, as found in other proteomics studies, 
increasing the level of fractionation increases the level of identifications. 
In addition to sample separation strategies, increasing the analysis time for one sample might increase 
protein coverage. This can be achieved by undertaking an extensive fractionation of proteins or peptides. For 
mouse faeces, filter assisted protein digestion (FASP), a protein digestion method which circumvents the in-
gel digestion, in combination with a gradient running for over eight hours, produced over 16,000 peptides in 
four runs (Tanca et al. 2014). The gain in functional information compared to other approaches was not 
detailed. The same group compared the effect of differential centrifugation and achieved an enrichment of 
microbial peptides when separating bacterial cells from other faecal components by applying different 
centrifugation speeds. The preparation of a microbial pellet resulted into the identification of approximately 
6,000 microbial peptides, whereas when the unseparated material was taken only around 4,000 peptides 
could be identified (Tanca et al. 2015). However, in the approach analysing the bacterial fraction, it appeared 
that the Bacteroidaceae were underrepresented. When comparing these other studies to the approach 
developed in this thesis (Study II), differences could be observed also at other steps of the pipeline, e.g. in 
the method of lysing the cells, the analytical platform used, as well as in the databases used (Table 7). These 
differences impair any direct comparison between the various studies. In general, the quantity and quality of 
fractionation and time spent per sample differs depending on which combination of techniques is selected. At 
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the functional level, no major discrepancies appeared when comparing the different studies based on the 
identified proteins (Study V). 
Table 7. Brief overview of examples for published method combinations in faecal metaproteomic experiments. 
Sample preparation Kolmeder et 
al. 2012 
Tanca et al. 2014 Erickson et al. 
2011 
Juste et al. 
2014 
Crude faecal material X    
Bacterial pellet 
 
 X X X 
Digestion     
In-gel digestion X   X 
FASEP  X   
In-solution 
 
  X  
Analytical platform     
2-DE    X 
SCX   X  
LC-MSMS moderate gradient < 3h X    
LC-MSMS Long gradient > 3h 
 
 X   
Protein sequence database     
Bacterial genomes X X X X 
Metagenomes X  X  
5.1.2 Reproducibility testing of the pipeline (II) 
The effect of sample preparation on the reproducibility of the LC-MS/MS results had to be determined in 
order to allow its application for robust sample comparisons. For this purpose, MS1 profiles were used, since 
with respect to the analytical outputs, they represent best the uniqueness of each in-gel digest. Replicates of 
the protein extraction, in-gel digestion, and LC-MS/MS were taken for comparison. In the analyses, samples 
from six biological samples were included representing three different individuals and two sampling time-
points. 
Altogether, the comparison was performed with 26,000 MS1 events across 22 AMPs. Based on Pearson 
correlation coefficients, the technical variation was compared to the variation of different samples from the 
same individual and in samples from different individuals (Figure 4). The technical variation, including the 
variation introduced by protein extraction, 1-DE/in-gel-digestion and LC-MS/MS analysis, was significantly 
lower than the variation of samples from the same individual collected on two different days with at least 
half a year time in-between. The variation observed in different samples from the same individual was 
significantly lower than the variation observed in samples taken from different individuals. This provided 
assurance that the developed approach could be applied in consecutive studies for comparing the 
functionalities of the intestinal microbiota across samples. 
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Figure 4. Boxplots of the distribution of the Pearson correlation coefficients (y-axis) to assess the effect of sample 
preparation, temporal and subject variation. 
5.1.3 Development of in-house databases (I-IV) 
One specific challenge in metaproteomics is the need for an adequate protein sequence database being a fair 
representation of the vast variety of different proteins present in the sample. The intestinal microbiota with 
the hundreds to thousands of different microbial species is an extreme version of this challenge. The 
individuality of the intestinal metaproteome and the consecutive required targeting of the database were 
demonstrated with metaproteome analysis of two samples for which the metagenomes had been analysed and 
were available for PSM i.e. matched metagenomes (Study I). Protein sequence databases were constructed 
by naïve translation of the metagenomes and these were used for PSM. By using the matched metagenome as 
the protein sequence database for PSM, it was possible to obtain double as many identified peptides than if 
one used the unmatched metagenome. In the same study, the following search strategy to increase the 
number of identified peptides was proposed; i) to use a collection of intestinal bacterial genomes as a 
database, called a synthetic metagenome, ii) perform a BLAST search with the hits from this search against a 
large metagenome database, iii) construct from these BLAST hits a protein sequence database and finally iv) 
perform PSM against this database and apply a conserved FDR of 1%. The aim was to increase per protein 
the sequence coverage by identified peptides, not to identify a large variety of functions. This approach of 
using an iterative workflow for PSM targeted the problem of impairing peptide identification on the basis of 
established validation strategies when the search sequence space becomes extremely large. In a classical 
proteomics experiment the database size is usually not larger than 10,000 sequences. However, the collection 
of metagenomic sequences used here contained 3,300,000 sequences (Qin et al. 2010). The result of doubling 
the number of identified peptides compared to the matched metagenome demonstrated the usefulness of the 
approach that could be applied in cases where extensive protein coverage is needed. Recently, other 
strategies for decreasing the size of the protein sequence database to aim for more specificity have been 
proposed. In one of these approaches a first search was conducted in a complex protein sequence database 
and a second search in a database constructed from the unfiltered results from the first search. The peptide 
identifications from the second search were subjected to strict FDR filtering (Jagtap et al. 2013). In another 
study, in a first search all the UniprotKB entries were used and then in a second search only the genomes of 
those microbial strains for which initially a hit had been found (Tanca et al. 2015). A systemic comparison of 
the available possibilities to increase the sensitivity of PSM in metaproteomics has yet to come. 
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Especially at the beginning of this work, having a matched metagenome of each analysed sample was 
not feasible due to the high costs. Therefore, it was decided to construct a database based on publically 
available sequences which would cover microbial, human and food derived proteins. During the course of 
this thesis work, the first comprehensive metagenome study was published (Kurokawa et al., 2007) followed 
by a human intestinal gene catalogue containing 3.3 Mio genes (Qin et al. 2010); the data of both studies was 
included into the protein sequence database constructed in-house. In addition, the protein sequence database 
contained a collection of intestinal microbial genomes; their number was initially 298 (Study II) but 
increased to 594 as more genomes became available (Studies III & IV). The human genome was included as 
well and extended for identifying alternative proteins in Studies III & IV. Finally, seven plant genomes were 
included in the protein sequence database that could be beneficial for identifying proteins present in food. 
The initial database contained 5,132,694 protein sequences (Study II) and the updated database 6,153,068 
(Studies III & IV). The extension of the protein sequence database plays a possible role in the increased 
identification ratios during the course of this thesis work (Table 8). 
The largest collection of genes derived from the intestinal microbiota covers now more than 10,000,000 
genes which may increase the ratio of identified peptides out of the metaproteomes (Karlsson et al. 2014). 
However, as exemplified in a recent study where the effect was tested of the size of the protein sequence 
database, it appeared that the optimum way of using this large sequence space still has to be determined 
(Muth et al. 2015). The more unique proteins that are present in a protein sequence database, the higher is the 
probability that peptides present in a sample will be identified due to the nature of PSM that allows only 
100% similar identifications. Conversely, the recent study by Muth and co-authors revealed that by using the 
present peptide validation strategy of FDR filtering, the sensitivity will suffer in the case of large databases, 
hampering utilizing its full potential. 
Table 8. Overview of MS/MS spectra and peptide identifications across studies 
 Study I * 
50 min gradient 
 
Study II** 
85 min gradient 
Study III ** 
Step-wise gradient 
70min + 30min 
Study IV** 
120 min gradient 
Number of MS/MS 
spectra per sample 
~45,000 ~4000 ~20,000 ~40,000 
Identification ratio 7.9 - 11.9%  ~17.0% ~24.0% ~27.0% 
*Different approach than used in Studies II-IV, 20 gel pieces covering full molecular weight range, each analysed with 
a 50 min gradient 
** AMP; see Table 6 in Material and Methods for differences in mass spectrometers used and other parameters between 
the studies 
5.1.4 Functional annotation with COG, KEGG and eggNOG (I-IV) 
Simply because of their extreme complexity and since the appropriate methods are still under development, 
most metagenomic sequences have not been well annotated. Hence, a strategy of annotating the identified 
proteins by orthologies was used. This orthology-based annotation facilitated the comparison between 
samples. Due to the problem of protein inference, which is particularly pronounced in metaproteomics, it is 
impossible to assign one protein solution for one peptide, the common unit in classical proteomics for 
making comparison between samples. In addition, default settings of search algorithms only provide a 
certain amount of proteins solutions for one peptide (e.g. 30 by OMSSA). However, as in the case of 
glutamate dehydrogenase, over 500 proteins from different bacteria share at least one peptide and often more 
peptides. Therefore, the initial search hits need to be remapped to the original protein sequence database with 
all options per tryptic peptide recorded, and then proteins should be grouped according to their peptide 
dependencies. In Study II proteins have been grouped based on having at least one peptide in common and 
one unique peptide. This is computationally demanding and as no ready applicable software solution is 
available for this task, it was only applied in Study II, with in-house scripts. Therefore, otherwise peptides 
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were functionally characterized based on the proteins they belonged to based on orthology and then the 
spectra per orthological functional category summed for subsequent quantitative comparisons. 
Out of the three orthological databases i.e. COG, KEGG and eggNOG, used for assigning a function to a 
peptide with eggNOG (Study IV) the highest functional assignation rate was obtained. For more than 90% of 
the spectra the respective proteins had a high confidence hit in the eggNOG database when applying a 
UBlast search (e-value of 1E-30 or lower); reflecting the suitability of this classification database of 
orthologous genes for annotating the human intestinal metaproteomes. The other databases COG and KEGG, 
which were used in studies II and III, covered around 70% of the identified spectra. All these orthological 
classification systems are based on a large collection of genomes from various sources and therefore they 
span a very broad range of functions. The description of the mapped orthologies is not always readily 
interpretable in the context of the human intestinal microbiota and may be viewed as rather abstract. 
Therefore, GMMs have been developed (Le Chatelier et al. 2013) that organize KOs into intestinal specific 
functional groups at three levels, such as mucin degradation or the degradation of carbohydrates, like 
arabinose and xylose (Study IV). These are meaningful categories and assist in the interpretation of the 
results. Characterization of protein functions can also be done based on the protein families database 
(PFAM) (Finn et al. 2014). This domain based functional annotation was not applied in this thesis work but 
has been previously used in metagenomic studies (Ellrott et al. 2010) and might be useful also in 
metaproteomics for functional description of proteins and sub sequential quantitative analysis for 
functionally targeted results. 
5.1.5 Reflections on the metaproteomic approach 
Taking into account that possibly 1000 microbial phylotypes are present in one individual intestine and that 
each of these phylotypes has a gene capacity of at least 2000 proteins, several millions of proteins could be 
present in one faecal sample. The proteins identified here obviously only reflect a very small fraction of the 
total proteins present in the samples. 
There are a few critical points that affect the success of a metaproteomic analysis. Sample preparation 
and protein or peptide fractionation strategies cannot be complete. However, the reproducibility can be 
assessed; based on a validated approach comparisons between samples can be made. In this work, the 
proteins were fractionated by molecular size which was then utilized in their subsequent selection and 
recovery. This process may have an effect on the identified proteins as only a subset of the proteins was 
analysed. Moreover, the recovery of the trypsin-digested peptides from the gel may be biased and affected by 
the amino acid sequences. In general, there exists no absolute bias-free proteomic technique, also not for 
metaproteomics and there is still potential for identifying more functions. To be kept in mind is that both the 
functional and taxonomic comparisons are based on identified spectra. This might introduce a further bias as 
it is of course not known which functions the not-identified proteins may have. They can be similar to those 
identified but they may also be different. Furthermore, a number of other parameters may introduce a bias, 
such as differences between search engines and their capacity to differentiate between similar peptides: with 
respect to the search results OMSSA for example is more conservative, tending to underrepresent, whereas 
X!Tandem has a tendency to over-represent. In addition, the more information is demanded for a peptide 
such as function and taxonomy, the smaller will become the remaining fraction for comparison; not all 
peptides have a taxonomy assigned and of these not all have an assigned function and vice versa. Therefore, 
improvements still can be made at all the various steps. The protein coverage needs to be increased by an 
optimized sample preparation method and analytical platform. However, careful evaluation is required that 
an accurate comparison between a large amount of samples is still possible. In addition, a cost-benefit 
analysis for the database searches is required with regard to the choice of search parameters and database 
size, all of which define the compute time and time spent on interpretation of the results, and peptide 
identification sensitivity (Muth et al. 2015). Similarly, peptide and protein validation methods for 
metaproteomics are required. Because of all these possible improvements, the here described approach 
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captures a fraction of the faecal proteins. However, it represents a feasible solution for comparing dozens of 
samples including the functional and taxonomic characterization of the identified peptides. Although there 
was a constant development of the metaproteomic pipeline throughout the project no major discrepancies 
were observed. This indicates that the developed approach provides a reliable access to the major proteins 
contained in faeces. 
In Study II, protein quantification was based on MS1 data, in all other studies quantification was 
performed by counting the identified spectra per comparative group e.g. specific phylum. Quantification 
based on MS1 peaks might be more robust for identifying differences in protein abundances between 
samples compared to spectral counting. However, applying the MS1 based approach in metaproteomics 
generates two challenges. The large protein diversity across metaproteomes poses a challenge to the aligning 
and normalizing algorithms of software for quantifying MS1 based data. Furthermore, the MS1 based 
approach relies on assigning peptides to proteins; some proteins like glutamate-dehydrogenase are 
conserved. It is very challenging to resolve several hundred proteins forming one protein cluster at the single 
protein level. Today’s increased computer power make it more realistic that the standard application of MS1 
based comparison in metaproteomics will come in the near future. 
5.2 Intestinal metaproteomic baseline of healthy individuals and its variation over time  
Having developed methods and strategies for faecal metaproteome analysis, the focus of this work was to 
describe the proteins found in healthy individuals and to create a healthy metaproteomic baseline. Health is a 
complex state defined by the WHO “as state of complete physical, mental and social well-being and not 
merely the absence of disease or infirmity”. In Study III, people were asked to grade their health (“good”, 
“average”, “poor”). Two individuals reported that they had average health but all others reported good 
health. In the other studies, the participants were not asked to classify their health. 
In Study III, in which samples of the largest healthy cohort studied for their metaproteome until now 
were analysed, 103 microbial KOs were found in each of the 16 individuals at least once. This can be 
considered as the functional core microbiome. The majority (62%) of these could be mapped on the KEGG 
metabolic pathways (Figure 5). These core metabolic functions, which were mainly involved in carbohydrate 
and amino acid, and energy metabolism, represent the backbone of the intestinal ecosystem. The coverage 
appears less compared to what was found in Study II. This can be explained by the fact that in Study II only 
three individuals were studied, whereas in Study III 16 individuals were studied. Similarly as observed for 
phylogenetic analysis and metagenomes, the larger the cohort is, the smaller the number of shared species or 
genes/functions might be (Jalanka-Tuovinen et al. 2011; Karlsson et al. 2014). 
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5.2.1 Individuality of the faecal metaproteome (II and III) 
One of the main findings of this work was that the intestinal metaproteome of a human being is highly 
individual. This extends previous findings on the personalized composition of the intestinal microbiota that 
has been reported extensively (Li et al. 2014). It was observed that the individuality of the metaproteomes 
remained both over the long term (one half to one year; based on MS1 level, Study II) and the short term (6 
weeks with probiotic intervention; Study III). Moreover, the personalized functional microbiome could be 
distinguished at both the peptide and KO level. This is an important finding as theoretically the individuality 
at the peptide level could be explained by genetic differences leading to amino acid differences. However, 
the observation that it was also found at the level of KOs, an abstract functional level, implies that there is a 
functional significance of the individuality. The individual variation exists in the type and extent of the 
cellular- and extracellular activities taking place in the intestinal ecosystem. These findings clearly go 
beyond metagenomic findings. Classifying genes to high functional level categories like COG families has 
revealed a rather homogenous distribution across individuals (Turnbaugh et al. 2009; Human Microbiome 
Project Consortium, 2012). However, most metagenomic studies have functionally not delved very deep into 
functional richness due to its obvious complexity. 
5.2.2 Main microbial functionalities (II and III) 
The main functionalities and special functions of the human intestinal microbiota explored by 
metaproteomics in this work clearly represent specific features of the ecosystem. Many proteins being 
involved in energy conversion were identified; these ranged from degrading both the initial food substrates, 
like arabinose isomerase for plant material degradation, and host derived, like fucosyl-isomerase to degrade 
fucose, up to the formation of intermediates such as butyrate and propionate by enzymes like butyryl-CoA 
dehydrogenase and methylmalonly CoA mutase. Clearly, generating energy for the microbial metabolism 
especially from carbohydrate sources appeared to be a characteristic of the intestinal microbiota, confirming 
earlier (meta-)genome-based observations. 
The maintenance of a redox-equilibrium is a very important task in an anaerobic environment. 
Rubrerythin was detected in the metaproteomes analysed in Study II and this protein could be involved in 
reducing oxidative damage by reducing peroxide to water. In addition, glutamate dehydrogenase was 
identified from several hundred microbes (Studies II & III). This protein may act as electron sink (Study II). 
The fact that high amounts of glutamate dehydrogenase were found highlights its functional importance as 
determined in a computational approach in which the functions found in a human derived metagenome were 
compared to metagenomes of other ecosystems (Ellrott et al. 2010). Furthermore, this demonstrates the 
capability of this metaproteomic approach to capture functional information from several hundreds of 
different species. 
The synthesis of vitamins like folate and vitamin B12 could be identified since it was possible to detect 
enzymes like formyltetrahydrofolate synthetase and cobalamin biosynthesis protein, respectively, in the 
metaproteomes analysed in Studies II and III. This does not imply that these vitamins are necessarily 
available to the host. However, it indicates that these vitamins may be required by the intestinal ecosystem. 
Interestingly, patients with IBD had a higher prevalence of deficiencies of folate and vitamin B12 (Bermejo 
et al. 2013). It is not to be excluded that the microbiota has a role in this phenomenon. In general, vitamin 
B12 was identified earlier as important factor in the intestine as both the host and the majority of intestinal 
microbes are requiring this vitamin, recently reviewed (Degnan et al. 2014). 
In general, in Study III it was possible to identify temporal and individual differences in all of the 
described functions. These identified microbial functions are evidence for the various metabolic activities 
taking place in the intestine and the changes occurring upon daily variations. Those proteins might be used as 
marker for the integrity of the microbial community. 
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In Study III, study participants had consumed a milk-based fruit drink with or without L. rhamnosus 
GG. Although, immunological experiments had revealed an effect by the consumption of L. rhamnosus GG 
(Kekkonen et al. 2008a), no changes to the functionalities were observed. A possible explanation for this 
might be that there were more pronounced changes in the ileum which were diluted in faecal material and 
could not be detected with the applied approach. 
5.3 Host-microbiota interactions (II-IV) 
The developed approach allowed identifying also human proteins. These constituted approximately 15% of 
the identified spectra. Identification of bacterial and host proteins in parallel resulted in the identification of 
various indications for host-microbiota interactions. Flagellins were detected in most of the intestinal 
metaproteomes (Studies I-IV). They are microbial proteins that make the cell motile. Moreover, flagellins are 
also known ligands of human toll-like receptor 5 and trigger the NFkB pathway (Vijay-Kumar et al. 2008). 
In Study III with the pro-inflammatory serine/threonine protein kinase 4 a human protein could be found 
significantly positively correlating with flagellins.  This may be an example of a host-microbe interaction i.e. 
the flagellins might be triggering the expression of serine/threonine kinase 4. Flagellins as component of the 
intestinal metaproteome were also found in a recent case study identifying the faecal proteins of one lean and 
one obese adolescent (Ferrer et al. 2013). In Study II, Eubacterium rectale and Roseburia intestinalis were 
identified as the possible sources of the flagellins. New intestinal species possessing the ability to produce 
flagellins have been recently identified, such as Lactobacillus ruminis (Neville et al. 2012). Elevated levels 
of flagellin-antigens have been found in patients with Crohn’s disease and post-infective IBS (Schoepfer et 
al. 2008). However, since they were detected also in healthy individuals, the presence of flagellins does not 
necessarily need to lead to inflammation. On the contrary, these microbial proteins could also stimulate the 
host in a beneficial way (Cullender et al. 2013). 
Human intestinal alkaline phosphatase is another protein that is involved in the inflammatory response. 
This protein was identified in the human metaproteome of several subjects (Studies II-IV). It was found in 
high amounts in obese and was one of the NOGs explaining the separation of samples between the obese and 
the non-obese group. It contributed up to 50% of the identified spectra with human origin. However, also in 
non-obese individuals, the levels of this enzyme could be high. The human IAP can bind bacterial 
lipopolysaccharides (LPS) and may therefore be controlling LPS-induced inflammation. Intestinal alkaline 
phosphatase has been used as a therapeutic agent for several conditions such as sepsis and is a well-studied 
enzyme. Several factors have been identified that affect its expression levels and enzyme activities, e.g. the 
type of blood group or pH (Estaki et al. 2014). Intestinal alkaline phosphatase might represent a good marker 
for regulative host processes allowing the gut to cope with changing environmental conditions. 
The intestinal tract is an ecosystem rich in food derived proteins and host and microbial derived 
proteins. Regulation of protein degradation is demonstrated by the identification of several proteinases but 
also proteinase inhibitors. Several decades ago, tryptic activity was detected in faecal samples derived from 
infants and therefore proteinases and their inhibitors were proposed to have a role in balancing intestinal 
functions (Norin et al. 1985). As discussed in the literature summary of this thesis, proteinases are also 
supposed to have another role in addition to proteolysis and it may be via these secondary roles that they 
contribute to a certain disease phenotype. 
Taken together, a combination of these proteins might be used as markers to monitor the health state of 
the intestinal ecosystem i.e. they could be used as indicators of an intact or perturbed system. 
Bacterial proteins degrading host derived glycans have been identified in many subjects (Study III), such 
as fucose isomerase which degrades mammalian derived glycans. In addition, also the host enzyme trehalase 
was identified; this is an enzyme that degrades trehalose, a disaccharide that is formed in bacteria upon stress 
to dehydration and acts as a compatible solute. These findings further illustrate the mutualistic relationship 
between the host and its microbes. 
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One example of indirect host-microbe interaction was observed in Study III in which two individuals 
exhibited relatively lower levels of alpha amylase and high levels of Prevotella ssp. peptide counts in 
comparison to the other individuals. This finding could indicate that these two individuals have consumed a 
diet not dominated by starch but containing more complex carbohydrates enforcing the activity of Prevotella. 
5.4 Comparing the metaproteome of lean and obese individuals (IV) 
Within this work, the microbial composition and metaproteome of a cohort of 29 non-obese and obese were 
analysed. In the samples deriving from the non-obese individuals, statistically significant higher levels of 
Bacteroidetes 16S rRNA were found compared to the obese individuals. However, relatively more 
Bacteroidetes peptides than 16S rRNA signals were obtained in the obese group compared to the non-obese 
group. 
It is unlikely that this is due to the greater faecal mass in obese individuals i.e. the relative share should 
not be affected as protein and DNA amounts should be affected similarly in that case. One explanation could 
be that there is an uncoupling between growth and activity, a well-known physiological phenomenon 
recognized in industrially-utilized bacteria such as Lactococcus lactis cultured at low pH conditions (Goel et 
al. 2015). It has been reported that the amount of SCFA were significantly higher in obese than in non-obese 
subjects (Fernandes et al. 2014), and as a result the colonic pH values of the obese subjects are predicted to 
be markedly lower.  In addition, it was found that the growth rate of Bacteroides spp. was tightly controlled 
and reduced at low pH and by the amount of SCFA (Duncan et al 2009). Hence, although the Bacteroides 
spp. may simply be not growing to high abundance due to the low pH in the obese subjects, these bacteria 
may still have very high activities. 
Yet another explanation could be a technical bias due to the phylogenetic analysis approach used or an 
incomplete coverage of the protein sequence database. Among the 957 cultured bacterial intestinal species 
47% belong to the phylum Firmicutes and 10% to Bacteroidetes (Rajilić-Stojanović and de Vos, 2014). Out 
of 398 strains at IMG/JGI for which there is an assigned origin in the digestive tract, 19% belong to the 
phylum Bacteroidetes (Figure 6). It is possible that the 16S rRNA sequences of the “obese” Bacteroidetes 
species are not fully covered by the oligonucleotide probes on the microarray. Alternatively, these “obese” 
Bacteroidetes species may be overrepresented in the protein databases used. The effect of ethnicity on the 
Bacteroidetes levels was revealed in a study on the microbiota and metagenome of obese compared to lean 
individuals (Turnbaugh et al. 2009). Lean individuals with European ancestry had 1.1 times more 
Bacteroidetes than their obese counterparts whereas the ratio was 1.3 for individuals of African ancestry. 
This might be due to the fact that the lean individuals of African ancestry had significantly more 
Bacteroidetes and less Firmicutes than the individuals of European ancestry. These findings exemplify the 
difficulties which may arise in comparing groups e.g. according their BMI values. 
The metaproteomes of the non-obese and obese group differed in a statistically significant way as shown 
by a principle coordinate analysis of the identified NOGs. This demonstrated that there are considerable 
differences in functionalities between the non-obese and obese group. Among the 25 NOGs which were 
found to explain the separation between samples from the obese and the non-obese group, based on 
baggedRDA analysis, several NOGs were involved in carbohydrate degradation. 
Furthermore, the insulin sensitivity of the subjects, as measured with the HOMA index, correlated 
negatively with a specific bacterial two component regulator. This is a further example of the link between 
microbiota and the host, and it may represent a possible starting point to clarify the reasons of the metabolic 
changes occurring in obesity. 
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Figure 6. Microbial phyla distribution of 1,847 microbial genomes at IMG/JGI with origin Homo sapiens (IMG/JGI 
HS), 398 of those are from the sub-system digestive tract (IMG/JGI HS DT), and of 1057 cultured intestinal phylotypes 
(1057). (EA = Euryarchaeota) 
5.5 Phylogeny-specific metabolic activity – 16S rRNA genes versus peptides analysis 
(II-IV) 
The recent expansion of the protein databases as consequence of the efforts ongoing in sequencing microbial 
genomes has provided a critical amount of microbial proteins sequences originating from a diverse range of 
species which made referring a LCA to a peptide possible. Furthermore, phylogenetic microarray data and 
metaproteomic data were compared to obtain a better understanding of which microbes were present and 
what was their metabolic activity. 
When comparing the phylum distributions measured by the phylogenetic microarray to the spectral 
count data of phylum-specific peptides both agreeing and disagreeing results were obtained (Figure 7). 
Differences in the averages per phylum were observed between Studies II, III and IV. Biological differences 
in the study cohorts, the storage of the faecal material (Table 5; Bahl et al. 2012) as well as differences in the 
analytical steps (Table 6) might have contributed to the observed differences. 
 
Figure 7. Barplot of the distribution of the main bacterial phyla across three studies assessed by phylogenetic 
microarray (16S) and metaproteomics analyses (pep). 
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The main functionalities were determined for the three major phyla found in the human intestine, 
Firmicutes, Bacteroidetes, and Actinobacteria. Firmicutes appeared to be dominantly active in carbohydrate 
metabolism and butyrate production, and Actinobacteria in sugar metabolism. The proteins produced by 
Bacteroidetes showed a more even distribution of several functions. These findings were in agreement with 
previous theoretical knowledge. Both in Study II and III, a large fraction of the identified peptides could not 
be assigned to proteins with any known function. This implies that the functionalities of Bacteroidetes are 
underrepresented in terms of cultured and sequenced species and hence need to be analysed more closely. 
In Study III, peptides were filtered according their phylogenetic origin and the KOs of these specific 
peptides were further studied. Specific focus was on the functionalities of Faecalibacterium prausnitzii, 
Prevotella ssp. and Methanobrevibacter as these organisms vary greatly in their abundance and encode 
distinct functions within the gut ecosystem. For F. prausnitzii for example glucuronate-isomerase was 
identified implying F. prausnitzii’s involvement in carbohydrate metabolism. According to the KOs that 
were identified based on Prevotella peptides these microbes contributed to the propionate synthesis in the 
analysed metaproteomes as methylmalonyl-CoA mutase was identified. In addition, proteins involved in the 
methane production derived from Methanobrevibacter were identified. 
The bias which remains in finding a LCA for a peptide and drawing a conclusion on these findings is 
that obviously not all peptides can be assigned. In this work the rate of assigning a LCA to a peptide was 
around 70%. An absolute peptide matching is required for assigning a phylogenetic origin to a peptide. 
However, this is impaired by the fact that many protein sequences still remain to be identified. Therefore, the 
results have to be seen in the light of present knowledge both in the form of oligonucleotides represented on 
the microarray as well as protein sequence entries in UniprotKB. 
In Study II, where aligned and normalized MS1 data for proteins were available the proteins could be 
correlated with the microarray data. Correlations for example between flagellin and Roseburia intestinalis 
and Eubacterium rectale could be identified. These findings could be verified by a BLAST search of the 
flagellin sequences. This highlights the fact that the integration of microarray and metaproteomic data makes 
it possible to identify the organisms responsible for the production of a specific protein. 
In Study I, it was noted that one of the individuals exhibited a high number of Akkermansia reads and 
similarly a high number of Akkermansia derived peptides could be identified. In the other individual, hardly 
any Akkermansia peptides were obtained. Akkermansia is so far the only member of the deeply rooted 
phylum Verrocumicrobia found in human GIT and therefore a good example for comparing 16S rRNA and 
peptide data. 
5.6 Reflections on study cohorts 
All the study participants but one (diabetes type II) were individuals without (chronic) disease. They had not 
taken any antibiotics at least three months prior to sampling and did not suffer from any gastro-intestinal 
diseases. Due to sample availability issues, some skewed age distribution was observed in the probiotic 
intervention trial (Study III). In the obesity study (Study IV) there was a significant age difference between 
the non-obese and the obese group. Generally, due to the small size of the cohorts, there was no even 
distribution between male and female study participants. 
With the exception of Study II which was a proof of principle study, all samples were derived from 
collaborations for which a number of meta-data was already available. Therefore, there was no influence on 
the availability of meta-data such as health-questionnaires or food diaries which were not collected. The 
absence of food diaries impaired controlling for the impact of diet that can be significant. For instance, 
without dietary information, it is difficult to account for the individual variation in some of the results 
obtained here, such as why flagellins are detected in some individuals and not in others. Similarly, in Study 
IV it remains unclear whether there is a per se difference in metabolism or if a difference in diet could 
explain the separation of the intestinal metaproteome from obese and non-obese subjects. 
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In Study III, study participants filled a symptom diary that indicated showing normal health 
perturbations such as loose stools or coughing. 
There is a learning process encountered when arranging this kind of study. Studies with human subjects 
depend very much on their willingness to participate and this may be lower in healthy subjects than in 
individuals with a disease who may hope that their participation will confer a health benefit. Since scientific 
interest in intestinal microbiota is still increasing, one can predict that larger studies also collecting faecal 
material or other digestive tract compartments will be conducted in the future. 
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6. CONCLUSIONS AND FUTURE PERSPECTIVES 
Microbiology has largely moved from light microscopy to what can be defined as “molecular microscopy”. 
By determining the sequences of 16S rRNA genes or metagenomes, a much larger variety of microbial 
communities has been discovered than ever would have been expected by looking at a microscopic picture or 
analysing colonies on a plate. The continuous development of both proteomics and the human microbiome 
field is reflected in the analytical capabilities of the different mass spectrometers used in this work, the 
development of available algorithms and other tools, and the constant increase in the numbers of microbial 
genes identified from the human intestine. 
The immense increase in genomic information of the intestinal microbiota has greatly facilitated studies 
at the protein level. However, the tremendous growth of sequence information has also hampered the 
potential identifications because of the great number of variations. Hence, it underlined the need for the 
development of new data analysis solutions. Proteomic software, such as is available for de novo sequencing, 
may further be developed to identify peptides in complex mixtures without the need for gene knowledge. 
Moreover, almost each year of this thesis work, an updated and faster or better mass spectrometer was 
introduced. 
The metaproteomic approach devised here is a detailed description of one solution for assessing the 
proteins contained in faecal material; as discussed, several other approaches are feasible.  With regard to the 
sample preparation, the development in metaproteomics has been parallel to that encountered in 
metagenomics. First, several different approaches have been proposed and now a systematic comparison is 
being undertaken (Salonen et al. 2010; Lozupone et al. 2013; Franzosa et al. 2014). An important point to 
keep in mind is that we are at the beginning of understanding the intestinal microbiome in its entirety by 
applying methods producing complex data-sets. These present studies highlighted the variety and complexity 
of the intestinal microbiome. After these initial studies, a refinement and homogenization of the analytical 
tools has started. In the field of metaproteomics, a systematic comparison of sample preparation 
methodologies has still to emerge and there are many important questions needing to be addressed. What is 
the effect of sampling? What is the effect of freezing and is there an effect of storage time? Which is better: 
using a bacterial pellet or utilizing crude faecal material? How should the lysis be performed: by mechanical 
disruption, chemical lysis, or a combination of these techniques? What is the best protein-fractionation 
method? In one study, the question of appropriate study material has now been addressed and the results 
indicate that by using a bacterial pellet one can recover more microbial proteins but with a bias in the 
recovered phyla (Tanca et al. 2015). It is to be expected that further methodological harmonization based on 
a comprehensive evaluation will accelerate the speed in acquiring new knowledge about the intestinal 
microbiota and its involvement in health and disease. 
Another approach that may be important in the future is the use of stable isotope probing. This approach 
can be coupled to dietary interventions with food components labelled with stable isotopes; this would make 
it possible to analyse trophic chains. Similarly, as it has been done for 16S rRNA analysis in an intestinal 
model and proteins in aquatic model systems, this technique could be applied to follow the human-microbial 
interactions in humans based by measuring the incorporation rates of these substrates into proteins. 
Two solutions for coping with protein inference that complicates quantitative comparisons between 
samples were applied. In Study II grouping proteins according their relatedness based on at least one shared 
peptide was used to resolve PSM results on the protein level. Another solution was devised by assigning 
peptides to functional groups and performing quantitative comparisons on that level. However, what is still 
needed is to define the functional-depth at which meaningful differences between treatment/health-state 
groups are found; if this is the individual protein deriving from a certain strain or species, a group of proteins 
sharing same peptides or proteins grouped to a specific function. Functional grouping of proteins as provided 
by the orthologous gene databases such as COG or eggNOG or the recently developed GMM are very useful 
in providing an overview of the functions taking place in a very complex ecosystem. One step further to the 
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defining of GMMs, grouping KOs to intestinal relevant functional categories, would be environment-specific 
annotation of human intestinal metagenomes. This requires experimental proofing of the predicted functions 
in combination with network analyses to test whether the predicted functions fit into the theoretical model. 
There is an overall awareness of the gene richness encoding for a large variety of functions of our 
microbes; and their importance for a multitude of body functions. However, there is still much to be learned 
of our microbes and us, in a world with usually a surplus of every food item. The mechanisms of interactions 
between host and microbiota are poorly understood. In the case of energy metabolism, recent research has 
opened up the possibly involved molecules and even genes. Bile acids are depending on the microbiota 
differently modified and these regulate the expression of the fxr gene, responsible for regulating host bile 
acid production. We need to concentrate again more on microbial physiology. Future efforts are to be taken 
to get to know yet un-cultured microbes and learn about their functions. Another possibility, closer to the in 
vivo situation, is to fractionate the intestinal microbes into distinct subsets, e.g. according to surface 
structure, and then to analyse their proteins. 
There is a large unknown gap between the potential and real functionalities of the intestinal microbiota; 
only half of the sequenced genes in metagenomic studies can be mapped to a gene homologue with a known 
function. The numbers of proteins detected in one faecal metaproteomics experiment are several factors of 
magnitude less than the theoretical number that could be detected. Some methods for fractionating the 
metaproteome have been described above. A further option for better capturing the full variety of proteins 
would be to utilize peptide ligand libraries as suggested recently (Righetti et al. 2015). Peptide ligand 
libraries could help to identify the less abundant proteins. 
Due to the multitude of factors affecting human metabolism and the composition and functions of our 
microbes, careful metadata collection, as well as phylogenetic and functional measurements, are required if 
we are to make meaningful associations. Data generated in such a way can be used to make predictions based 
on profiling data and it can be applied for diagnosis of an individual’s health state or the decision what would 
be the most successful treatment. As shown in this work, we have a personalized metaproteome and there is 
temporal variation of its functions. By conducting longitudinal studies, well-controlled for possible 
influencing factors, we may be able to determine which microbial set-ups are associated with which and 
which effectors change the property and if so, to which extent. 
Although the main purpose of metaproteomics is not to identify which organisms are present in the 
microbial community but instead to study its function, in this work the method of assigning a phylogenetic 
origin to a peptide was found useful in the handling of such complex data. Sub-setting the identifications into 
host and bacterial proteins revealed component specific proteins. 
 Phylogenetic analyses complemented the metaproteomic data in this work. Although both 
sequencing and proteomics techniques developed tremendously during the course of this work, biases from 
both sides remain, complicating the one-to-one comparison. Until these biases are further tackled, any 
comparisons have to be viewed as approximations. A major divergence was observed between phylogenetic 
microarray analysis and metaproteomics for members of the genus Bacteroides. Whereas on the 16S rRNA 
level Bacteroides spp. were apparently significantly less abundant in obese individuals, relatively more 
Bacteroides peptides were identified from the obese individuals. While the simple explanation is that the 
Bacteroides spp. are more active in the obese subjects, the question arises why they are then not simply 
outgrowing and become more abundant. Consequential studies may provide further evidence that there is an 
uncoupling between growth and activity. 
There is a perceived need for studying the proteins in the upper regions of the GIT in addition to the 
studies so far mostly focused on faecal material. One study used lavage to sample proteins along the intestine 
(Li et al. 2011).  However, this study focused on extracellular proteins and no attempts were made to lyse the 
microbes that could have been present. Sampling in a way comparably to the one carried out in a rat study, in 
which the metaproteome of different intestinal compartments were analysed (Haange et al. 2012), would 
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contribute to describe in humans the spatial functional differences along – from proximal to distal, and across 
the intestinal tract – from epithelium to lumen. 
We have learned by using techniques of modern molecular biology and keen interest in the ongoing 
activities inside of our body that we require our microbes and our microbes require us for keeping a healthy 
body condition. Careful study of the vast information on the intestinal microbiota and expanding it with 
targeted new studies in a team of clinicians, microbiologists, nutrition scientists and bioinformaticians, will 
sharpen our insights of the complex mechanisms ongoing inside us. 
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